No., subject, TM-score, RMSD, Sequence Identity, Subject length, Aligned length, Description
1, d1f9qA_, 1.0000, 0.00, 1.000, 64, 64, CRYSTAL STRUCTURE OF PLATELET FACTOR 4
2, d1f9rA_, 0.9835, 0.36, 0.953, 65, 64, CRYSTAL STRUCTURE OF PLATELET FACTOR 4 MUTANT 1
3, d1f9sA_, 0.9723, 0.47, 0.984, 66, 64, CRYSTAL STRUCTURE OF PLATELET FACTOR 4 MUTANT 2
4, d4r9wB_, 0.9607, 0.57, 1.000, 64, 64, CRYSTAL STRUCTURE OF PLATELET FACTOR 4 COMPLEXED WITH FONDAPARINUX
5, d1plfD_, 0.9546, 0.67, 0.766, 65, 64, THE THREE-DIMENSIONAL STRUCTURE OF BOVINE PLATELET FACTOR 4 AT 3.0 ANGSTROMS RESOLUTION
6, d1f9qD_, 0.9405, 0.91, 1.000, 66, 64, CRYSTAL STRUCTURE OF PLATELET FACTOR 4
7, d1rhpD_, 0.9404, 0.73, 1.000, 64, 64, CRYSTAL STRUCTURE OF RECOMBINANT HUMAN PLATELET FACTOR 4
8, d1rhpB_, 0.9384, 0.78, 1.000, 64, 64, CRYSTAL STRUCTURE OF RECOMBINANT HUMAN PLATELET FACTOR 4
9, d1plfB_, 0.9341, 0.78, 0.766, 65, 64, THE THREE-DIMENSIONAL STRUCTURE OF BOVINE PLATELET FACTOR 4 AT 3.0 ANGSTROMS RESOLUTION
10, d1f9rD_, 0.9246, 1.04, 0.953, 65, 64, CRYSTAL STRUCTURE OF PLATELET FACTOR 4 MUTANT 1
11, d1rhpC_, 0.9203, 0.90, 1.000, 64, 64, CRYSTAL STRUCTURE OF RECOMBINANT HUMAN PLATELET FACTOR 4
12, d1plfA_, 0.9181, 1.10, 0.762, 63, 63, THE THREE-DIMENSIONAL STRUCTURE OF BOVINE PLATELET FACTOR 4 AT 3.0 ANGSTROMS RESOLUTION
13, d1plfC_, 0.9154, 0.82, 0.762, 63, 63, THE THREE-DIMENSIONAL STRUCTURE OF BOVINE PLATELET FACTOR 4 AT 3.0 ANGSTROMS RESOLUTION
14, d1f9sD_, 0.9145, 1.05, 0.984, 65, 64, CRYSTAL STRUCTURE OF PLATELET FACTOR 4 MUTANT 2
15, d1f9rC_, 0.9094, 0.75, 0.952, 65, 62, CRYSTAL STRUCTURE OF PLATELET FACTOR 4 MUTANT 1
16, d1f9qC_, 0.8952, 1.10, 1.000, 62, 62, CRYSTAL STRUCTURE OF PLATELET FACTOR 4
17, d1f9rB_, 0.8857, 1.03, 0.952, 63, 62, CRYSTAL STRUCTURE OF PLATELET FACTOR 4 MUTANT 1
18, d5ob5A_, 0.8822, 1.16, 0.444, 63, 63, FAB COMPLEX WITH GROBETA. ABVANCE: INCREASING OUR KNOWLEDGE OF ANTIBODY STRUCTURAL SPACE TO ENABLE FASTER AND BETTER DECISION-MAKING IN ANTIBODY DRUG DISCOVERY.
19, d1f9qB_, 0.8790, 1.07, 1.000, 62, 62, CRYSTAL STRUCTURE OF PLATELET FACTOR 4
20, d1rhpA_, 0.8770, 1.62, 1.000, 64, 64, CRYSTAL STRUCTURE OF RECOMBINANT HUMAN PLATELET FACTOR 4
21, d1f9sB_, 0.8714, 1.12, 0.984, 62, 62, CRYSTAL STRUCTURE OF PLATELET FACTOR 4 MUTANT 2
22, d1f9sC_, 0.8696, 1.09, 0.984, 62, 62, CRYSTAL STRUCTURE OF PLATELET FACTOR 4 MUTANT 2
23, p4r9yA_, 0.8640, 1.24, 1.000, 65, 64, CRYSTAL STRUCTURE OF KKOFAB IN COMPLEX WITH PLATELET FACTOR 4
24, p4r9yB_, 0.8626, 1.25, 1.000, 65, 64, CRYSTAL STRUCTURE OF KKOFAB IN COMPLEX WITH PLATELET FACTOR 4
25, d4r9wA_, 0.8542, 1.50, 1.000, 62, 62, CRYSTAL STRUCTURE OF PLATELET FACTOR 4 COMPLEXED WITH FONDAPARINUX
26, d3n52D_, 0.8539, 1.34, 0.500, 70, 64, CRYSTAL STRUCTURE ANALYSIS OF MIP2
27, d1napB_, 0.8526, 1.24, 0.578, 66, 64, THE CRYSTAL STRUCTURE OF RECOMBINANT HUMAN NEUTROPHIL- ACTIVATING PEPTIDE-2 (M6L) AT 1.9-ANGSTROMS RESOLUTION
28, d1tvxA_, 0.8522, 1.18, 0.587, 64, 63, NEUTROPHIL ACTIVATING PEPTIDE-2 VARIANT FORM M6L WITH FIVE ADDITIONAL AMINO TERMINAL RESIDUES (DSDLY)
29, d3n52A_, 0.8511, 1.33, 0.500, 67, 64, CRYSTAL STRUCTURE ANALYSIS OF MIP2
30, d3n52C_, 0.8486, 1.35, 0.500, 67, 64, CRYSTAL STRUCTURE ANALYSIS OF MIP2
31, d1tvxD_, 0.8475, 1.24, 0.578, 71, 64, NEUTROPHIL ACTIVATING PEPTIDE-2 VARIANT FORM M6L WITH FIVE ADDITIONAL AMINO TERMINAL RESIDUES (DSDLY)
32, d1tvxC_, 0.8472, 1.21, 0.587, 64, 63, NEUTROPHIL ACTIVATING PEPTIDE-2 VARIANT FORM M6L WITH FIVE ADDITIONAL AMINO TERMINAL RESIDUES (DSDLY)
33, d1f9pA_, 0.8432, 1.48, 0.571, 81, 63, CRYSTAL STRUCTURE OF CONNECTIVE TISSUE ACTIVATING PEPTIDE- III(CTAP-III) COMPLEXED WITH POLYVINYLSULFONIC ACID
34, d1tvxB_, 0.8420, 1.48, 0.571, 81, 63, NEUTROPHIL ACTIVATING PEPTIDE-2 VARIANT FORM M6L WITH FIVE ADDITIONAL AMINO TERMINAL RESIDUES (DSDLY)
35, d1napD_, 0.8419, 1.27, 0.578, 71, 64, THE CRYSTAL STRUCTURE OF RECOMBINANT HUMAN NEUTROPHIL- ACTIVATING PEPTIDE-2 (M6L) AT 1.9-ANGSTROMS RESOLUTION
36, d3il8A_, 0.8396, 1.28, 0.578, 66, 64, CRYSTAL STRUCTURE OF INTERLEUKIN 8: SYMBIOSIS OF NMR AND CRYSTALLOGRAPHY
37, d1napA_, 0.8376, 1.28, 0.381, 68, 63, THE CRYSTAL STRUCTURE OF RECOMBINANT HUMAN NEUTROPHIL- ACTIVATING PEPTIDE-2 (M6L) AT 1.9-ANGSTROMS RESOLUTION
38, d1napC_, 0.8305, 1.66, 0.562, 66, 64, THE CRYSTAL STRUCTURE OF RECOMBINANT HUMAN NEUTROPHIL- ACTIVATING PEPTIDE-2 (M6L) AT 1.9-ANGSTROMS RESOLUTION
39, d5d14A_, 0.8295, 1.19, 0.581, 63, 62, THE ATOMIC RESOLUTION CRYSTAL STRUCTURE OF HUMAN IL-8
40, d4xdxA_, 0.8293, 1.59, 0.375, 70, 64, THE CRYSTAL STRUCTURE OF SOLUBLE HUMAN INTERLEUKIN 8 EXPRESSED IN PICHIA PASTORIS
41, d1qe6A_, 0.8289, 1.61, 0.375, 70, 64, INTERLEUKIN-8 WITH AN ADDED DISULFIDE BETWEEN RESIDUES 5 AND 33 (L5C/H33C)
42, d1qe6D_, 0.8284, 1.28, 0.349, 68, 63, INTERLEUKIN-8 WITH AN ADDED DISULFIDE BETWEEN RESIDUES 5 AND 33 (L5C/H33C)
43, p4r9yD_, 0.8238, 1.33, 0.344, 72, 64, CRYSTAL STRUCTURE OF KKOFAB IN COMPLEX WITH PLATELET FACTOR 4
44, d3n52B_, 0.8231, 1.33, 0.344, 72, 64, CRYSTAL STRUCTURE ANALYSIS OF MIP2
45, d1mgsB_, 0.8222, 1.43, 1.000, 65, 64, THE SOLUTION STRUCTURE OF MELANOMA GROWTH STIMULATING ACTIVITY
46, d1mgsA_, 0.8222, 1.60, 0.500, 71, 64, THE SOLUTION STRUCTURE OF MELANOMA GROWTH STIMULATING ACTIVITY
47, p4r9yC_, 0.8186, 1.45, 0.484, 73, 64, CRYSTAL STRUCTURE OF KKOFAB IN COMPLEX WITH PLATELET FACTOR 4
48, d1o80B_, 0.8178, 1.45, 0.484, 73, 64, CRYSTAL STRUCTURE OF IP-10 H-FORM
49, d1o7yC_, 0.8177, 1.46, 1.000, 65, 64, CRYSTAL STRUCTURE OF IP-10 M-FORM
50, d1qnkB_, 0.8159, 1.52, 0.297, 71, 64, TRUNCATED HUMAN GROB[5-73] NMR 20 STRUCTURES
51, d1qe6B_, 0.8150, 1.23, 0.361, 63, 61, INTERLEUKIN-8 WITH AN ADDED DISULFIDE BETWEEN RESIDUES 5 AND 33 (L5C/H33C)
52, d1icwA_, 0.8137, 1.56, 0.437, 69, 64, INTERLEUKIN-8 MUTANT WITH GLU 38 REPLACED BY CYS AND CYS 50 REPLACED BY ALA
53, d1o7yA_, 0.8086, 1.48, 0.344, 71, 64, CRYSTAL STRUCTURE OF IP-10 M-FORM
54, d2mgsA_, 0.8059, 1.39, 0.359, 69, 64, SOLUTION STRUCTURE OF CXCL5
55, d1o7yD_, 0.7954, 1.43, 0.339, 67, 62, CRYSTAL STRUCTURE OF IP-10 M-FORM
56, d1dokA_, 0.7952, 1.66, 0.453, 71, 64, MONOCYTE CHEMOATTRACTANT PROTEIN 1 P-FORM
57, d1ilqB_, 0.7941, 1.24, 0.367, 62, 60, CXCR-1 N-TERMINAL PEPTIDE BOUND TO INTERLEUKIN-8 (MINIMIZED MEAN)
58, d1il8B_, 0.7941, 1.71, 0.175, 72, 63, THREE-DIMENSIONAL STRUCTURE OF INTERLEUKIN 8 IN SOLUTION
59, d1il8A_, 0.7941, 1.72, 0.359, 71, 64, THREE-DIMENSIONAL STRUCTURE OF INTERLEUKIN 8 IN SOLUTION
60, d1ilpB_, 0.7940, 1.72, 0.359, 71, 64, CXCR-1 N-TERMINAL PEPTIDE BOUND TO INTERLEUKIN-8
61, d1icwB_, 0.7937, 1.72, 0.359, 71, 64, INTERLEUKIN-8 MUTANT WITH GLU 38 REPLACED BY CYS AND CYS 50 REPLACED BY ALA
62, d1qe6C_, 0.7926, 1.72, 0.359, 71, 64, INTERLEUKIN-8 WITH AN ADDED DISULFIDE BETWEEN RESIDUES 5 AND 33 (L5C/H33C)
63, d2il8B_, 0.7891, 1.36, 0.361, 66, 61, THREE-DIMENSIONAL STRUCTURE OF INTERLEUKIN 8 IN SOLUTION
64, d2il8A_, 0.7891, 1.44, 0.355, 67, 62, THREE-DIMENSIONAL STRUCTURE OF INTERLEUKIN 8 IN SOLUTION
65, d1qnkA_, 0.7884, 1.78, 0.365, 71, 63, TRUNCATED HUMAN GROB[5-73] NMR 20 STRUCTURES
66, d2mgsB_, 0.7876, 1.78, 0.365, 71, 63, SOLUTION STRUCTURE OF CXCL5
67, d1o7yB_, 0.7869, 1.67, 0.437, 69, 64, CRYSTAL STRUCTURE OF IP-10 M-FORM
68, d5ur7B_, 0.7777, 1.74, 0.453, 71, 64, CRYSTAL STRUCTURE OF ENGINEERED CCL20 DISULFIDE LOCKED DIMER
69, d1ilpA_, 0.7772, 1.34, 0.350, 62, 60, CXCR-1 N-TERMINAL PEPTIDE BOUND TO INTERLEUKIN-8
70, d4xt1B_, 0.7771, 1.55, 0.197, 66, 61, STRUCTURE OF A NANOBODY-BOUND VIRAL GPCR BOUND TO HUMAN CHEMOKINE CX3CL1
71, d1ilqA_, 0.7763, 1.74, 0.375, 71, 64, CXCR-1 N-TERMINAL PEPTIDE BOUND TO INTERLEUKIN-8 (MINIMIZED MEAN)
72, d1dokB_, 0.7760, 1.80, 0.194, 67, 62, MONOCYTE CHEMOATTRACTANT PROTEIN 1 P-FORM
73, d1f2lA_, 0.7752, 1.76, 0.359, 71, 64, CRYSTAL STRUCTURE OF CHEMOKINE DOMAIN OF FRACTALKINE
74, d2bdnA1, 0.7721, 1.83, 0.175, 72, 63, CRYSTAL STRUCTURE OF HUMAN MCP-1 BOUND TO A BLOCKING ANTIBODY 11K2
75, d1f2lD_, 0.7712, 2.10, 0.194, 64, 62, CRYSTAL STRUCTURE OF CHEMOKINE DOMAIN OF FRACTALKINE
76, p4xt3B_, 0.7710, 2.03, 0.175, 68, 63, STRUCTURE OF A VIRAL GPCR BOUND TO HUMAN CHEMOKINE CX3CL1
77, p3ifdA_, 0.7695, 1.85, 0.194, 70, 62, HUMAN SYNTHETIC MONOCYTE CHEMOATTRACTANT PROTEIN 1 (MCP-1)
78, d4hsvD_, 0.7676, 1.81, 0.194, 68, 62, CRYSTAL STRUCTURE OF CXCL4L1
79, d4hsvA_, 0.7673, 1.90, 0.177, 66, 62, CRYSTAL STRUCTURE OF CXCL4L1
80, d5ur7A_, 0.7662, 1.72, 0.964, 65, 55, CRYSTAL STRUCTURE OF ENGINEERED CCL20 DISULFIDE LOCKED DIMER
81, d1f2lC_, 0.7654, 1.94, 0.946, 65, 56, CRYSTAL STRUCTURE OF CHEMOKINE DOMAIN OF FRACTALKINE
82, d1o7zA_, 0.7645, 1.70, 0.197, 66, 61, CRYSTAL STRUCTURE OF IP-10 T-FORM
83, d1f2lB_, 0.7638, 2.18, 0.194, 64, 62, CRYSTAL STRUCTURE OF CHEMOKINE DOMAIN OF FRACTALKINE
84, d1dolA_, 0.7635, 1.36, 0.328, 60, 58, MONOCYTE CHEMOATTRACTANT PROTEIN 1 I-FORM
85, d4zk9B_, 0.7622, 1.94, 0.194, 64, 62, ORF CHEMOKINE BINDING PROTEIN COMPLEXED WITH CCL2
86, p4r8iA_, 0.7618, 2.09, 0.177, 71, 62, HIGH RESOLUTION STRUCTURE OF A MIRROR-IMAGE RNA OLIGONUCLEOTIDE APTAMER IN COMPLEX WITH THE CHEMOKINE CCL2
87, d1o80A_, 0.7607, 1.70, 0.183, 61, 60, CRYSTAL STRUCTURE OF IP-10 H-FORM
88, d2nz1Y_, 0.7589, 2.04, 0.175, 68, 63, VIRAL CHEMOKINE BINDING PROTEIN M3 FROM MURINE GAMMAHERPESVIRUS68 IN COMPLEX WITH THE CC-CHEMOKINE CCL2/MCP-1
89, p4dn4M_, 0.7581, 1.83, 0.328, 74, 64, CRYSTAL STRUCTURE OF THE COMPLEX BETWEEN CNTO888 FAB AND MCP-1 MUTANT P8A
90, d2nz1E_, 0.7575, 1.83, 0.328, 74, 64, VIRAL CHEMOKINE BINDING PROTEIN M3 FROM MURINE GAMMAHERPESVIRUS68 IN COMPLEX WITH THE CC-CHEMOKINE CCL2/MCP-1
91, d5coyA_, 0.7560, 1.99, 0.194, 64, 62, CRYSTAL STRUCTURE OF CC CHEMOKINE 5 (CCL5)
92, d2nz1D_, 0.7544, 1.56, 0.153, 61, 59, VIRAL CHEMOKINE BINDING PROTEIN M3 FROM MURINE GAMMAHERPESVIRUS68 IN COMPLEX WITH THE CC-CHEMOKINE CCL2/MCP-1
93, d1pfmC_, 0.7543, 2.00, 0.194, 64, 62, PF4-M2 CHIMERIC MUTANT WITH THE FIRST 10 N-TERMINAL RESIDUES OF R-PF4 REPLACED BY THE N-TERMINAL RESIDUES OF THE IL8 SEQUENCE. MODELS 1-15 OF A 27-MODEL SET.
94, p5wb2B_, 0.7541, 1.99, 0.145, 65, 62, US28 BOUND TO ENGINEERED CHEMOKINE CX3CL1.35 AND NANOBODIES 
95, d2l9hC_, 0.7538, 2.02, 0.194, 64, 62, OLIGOMERIC STRUCTURE OF THE CHEMOKINE CCL5/RANTES FROM NMR MS AND SAXS DATA
96, d1pfmD_, 0.7538, 2.03, 0.953, 68, 64, PF4-M2 CHIMERIC MUTANT WITH THE FIRST 10 N-TERMINAL RESIDUES OF R-PF4 REPLACED BY THE N-TERMINAL RESIDUES OF THE IL8 SEQUENCE. MODELS 1-15 OF A 27-MODEL SET.
97, d2l9hA_, 0.7532, 1.97, 0.177, 73, 62, OLIGOMERIC STRUCTURE OF THE CHEMOKINE CCL5/RANTES FROM NMR MS AND SAXS DATA
98, d1pfmB_, 0.7530, 1.98, 0.145, 67, 62, PF4-M2 CHIMERIC MUTANT WITH THE FIRST 10 N-TERMINAL RESIDUES OF R-PF4 REPLACED BY THE N-TERMINAL RESIDUES OF THE IL8 SEQUENCE. MODELS 1-15 OF A 27-MODEL SET.
99, d2x6gF_, 0.7529, 1.97, 0.968, 68, 63, X-RAY STRUCTURE OF MACROPHAGE INFLAMMATORY PROTEIN-1 ALPHA (D27A)
100, d1u4lA_, 0.7529, 1.98, 0.145, 67, 62, HUMAN RANTES COMPLEXED TO HEPARIN-DERIVED DISACCHARIDE I-S
101, d1m8aB_, 0.7513, 1.99, 0.968, 68, 63, HUMAN MIP-3ALPHA/CCL20
102, d1pfmA_, 0.7508, 1.91, 0.213, 66, 61, PF4-M2 CHIMERIC MUTANT WITH THE FIRST 10 N-TERMINAL RESIDUES OF R-PF4 REPLACED BY THE N-TERMINAL RESIDUES OF THE IL8 SEQUENCE. MODELS 1-15 OF A 27-MODEL SET.
103, d5ekiA_, 0.7507, 1.98, 0.145, 67, 62, CRYSTAL STRUCTURE OF TRUNCATED CCL21
104, d1ml0D_, 0.7506, 1.63, 0.200, 61, 60, VIRAL CHEMOKINE BINDING PROTEIN M3 FROM MURINE GAMMAHERPESVIRUS68 IN COMPLEX WITH THE P8A VARIANT OF CC-CHEMOKINE MCP-1
105, d2x6gJ_, 0.7502, 1.99, 0.968, 68, 63, X-RAY STRUCTURE OF MACROPHAGE INFLAMMATORY PROTEIN-1 ALPHA (D27A)
106, d2hciB1, 0.7487, 1.82, 0.113, 72, 62, STRUCTURE OF HUMAN MIP-3A CHEMOKINE
107, d4zltF_, 0.7485, 2.02, 0.194, 64, 62, CRYSTAL STRUCTURE OF VIRAL CHEMOKINE BINDING PROTEIN R17 IN COMPLEX WITH CCL3
108, d1u4mA_, 0.7475, 2.11, 0.226, 65, 62, HUMAN RANTES COMPLEXED TO HEPARIN-DERIVED DISACCHARIDE III-S
109, d2r3zC_, 0.7468, 1.72, 0.200, 61, 60, CRYSTAL STRUCTURE OF MOUSE IP-10
110, d5corA_, 0.7467, 1.93, 0.183, 62, 60, X-RAY STRUCTURE OF MACROPHAGE INFLAMMATORY PROTEIN-1 ALPHA (CCL3) N- TERMINAL-SWITCH POLYMER
111, d2x6gC_, 0.7464, 2.01, 0.145, 67, 62, X-RAY STRUCTURE OF MACROPHAGE INFLAMMATORY PROTEIN-1 ALPHA (D27A)
112, d2x6gD_, 0.7461, 2.18, 0.344, 65, 61, X-RAY STRUCTURE OF MACROPHAGE INFLAMMATORY PROTEIN-1 ALPHA (D27A)
113, d1esrA_, 0.7444, 2.00, 0.226, 70, 62, CRYSTAL STRUCTURE OF HUMAN MONOCYTE CHEMOTACTIC PROTEIN-2
114, d1nr4G_, 0.7442, 1.96, 0.213, 65, 61, HIGH RESOLUTION CRYSTAL STRUCTURES OF THYMUS AND ACTIVATION- REGULATED CHEMOKINE
115, d1nr4A_, 0.7438, 2.10, 0.226, 65, 62, HIGH RESOLUTION CRYSTAL STRUCTURES OF THYMUS AND ACTIVATION- REGULATED CHEMOKINE
116, d5corJ_, 0.7433, 2.00, 0.175, 75, 63, X-RAY STRUCTURE OF MACROPHAGE INFLAMMATORY PROTEIN-1 ALPHA (CCL3) N- TERMINAL-SWITCH POLYMER
117, d3tn1D1, 0.7429, 2.02, 0.177, 66, 62,  
118, d4mheD_, 0.7428, 2.00, 0.177, 67, 62, CRYSTAL STRUCTURE OF CC-CHEMOKINE 18
119, d1b3aA_, 0.7426, 2.03, 0.226, 70, 62, TOTAL CHEMICAL SYNTHESIS AND HIGH-RESOLUTION CRYSTAL STRUCTURE OF THE POTENT ANTI-HIV PROTEIN AOP-RANTES
120, d5corF_, 0.7423, 1.94, 0.213, 67, 61, X-RAY STRUCTURE OF MACROPHAGE INFLAMMATORY PROTEIN-1 ALPHA (CCL3) N- TERMINAL-SWITCH POLYMER
121, d5corG_, 0.7422, 1.59, 0.271, 60, 59, X-RAY STRUCTURE OF MACROPHAGE INFLAMMATORY PROTEIN-1 ALPHA (CCL3) N- TERMINAL-SWITCH POLYMER
122, d1nr4C_, 0.7415, 2.04, 0.145, 67, 62, HIGH RESOLUTION CRYSTAL STRUCTURES OF THYMUS AND ACTIVATION- REGULATED CHEMOKINE
123, p2x69D_, 0.7407, 2.01, 0.226, 70, 62, X-RAY STRUCTURE OF MACROPHAGE INFLAMMATORY PROTEIN-1 ALPHA POLYMER
124, d2x6gE_, 0.7405, 2.02, 0.226, 70, 62, X-RAY STRUCTURE OF MACROPHAGE INFLAMMATORY PROTEIN-1 ALPHA (D27A)
125, d5cmdA_, 0.7402, 2.00, 0.177, 66, 62, OLIGOMER CRYSTAL STRUCTURE OF CC CHEMOKINE 5 (CCL5)
126, d5corD_, 0.7400, 1.96, 0.213, 66, 61, X-RAY STRUCTURE OF MACROPHAGE INFLAMMATORY PROTEIN-1 ALPHA (CCL3) N- TERMINAL-SWITCH POLYMER
127, d2r3zD_, 0.7400, 2.14, 0.226, 66, 62, CRYSTAL STRUCTURE OF MOUSE IP-10
128, d5dnfG_, 0.7395, 2.07, 0.161, 64, 62, CRYSTAL STRUCTURE OF CC CHEMOKINE 5 (CCL5) OLIGOMER IN COMPLEX WITH HEPARIN
129, d5ekiE_, 0.7394, 1.98, 0.197, 68, 61, CRYSTAL STRUCTURE OF TRUNCATED CCL21
130, d1eqtA_, 0.7393, 1.46, 0.362, 64, 58, MET-RANTES
131, d4zltL_, 0.7388, 2.09, 0.145, 65, 62, CRYSTAL STRUCTURE OF VIRAL CHEMOKINE BINDING PROTEIN R17 IN COMPLEX WITH CCL3
132, d2x6gB_, 0.7388, 1.89, 0.113, 73, 62, X-RAY STRUCTURE OF MACROPHAGE INFLAMMATORY PROTEIN-1 ALPHA (D27A)
133, d4ra8D_, 0.7384, 1.89, 0.113, 73, 62, STRUCTURE ANALYSIS OF THE MIP1A P8A MUTANT
134, p2nyzD_, 0.7384, 2.04, 0.145, 67, 62, VIRAL CHEMOKINE BINDING PROTEIN M3 FROM MURINE GAMMAHERPESVIRUS68 IN COMPLEX WITH THE C- CHEMOKINE XCL1
135, d1nr4E_, 0.7382, 1.92, 0.183, 62, 60, HIGH RESOLUTION CRYSTAL STRUCTURES OF THYMUS AND ACTIVATION- REGULATED CHEMOKINE
136, d3onaB_, 0.7379, 1.96, 0.213, 65, 61, THE SECRET DOMAIN IN COMPLEX WITH CX3CL1
137, d1nr4F_, 0.7379, 1.97, 0.213, 65, 61, HIGH RESOLUTION CRYSTAL STRUCTURES OF THYMUS AND ACTIVATION- REGULATED CHEMOKINE
138, d3tn1E1, 0.7375, 1.71, 0.207, 61, 58,  
139, d5ekiD_, 0.7371, 2.04, 0.177, 69, 62, CRYSTAL STRUCTURE OF TRUNCATED CCL21
140, d1m8aA_, 0.7367, 2.04, 0.177, 69, 62, HUMAN MIP-3ALPHA/CCL20
141, d1domB_, 0.7367, 2.01, 0.200, 66, 60, SOLUTION STRUCTURE OF THE MONOCYTE CHEMOATTRACTANT PROTEIN- 1 DIMER USING HETERONUCLEAR NMR MINIMIZED AVERAGE STRUCTURE
142, d1domA_, 0.7367, 2.18, 0.177, 66, 62, SOLUTION STRUCTURE OF THE MONOCYTE CHEMOATTRACTANT PROTEIN- 1 DIMER USING HETERONUCLEAR NMR MINIMIZED AVERAGE STRUCTURE
143, d5d65C_, 0.7365, 2.03, 0.213, 67, 61, X-RAY STRUCTURE OF MACROPHAGE INFLAMMATORY PROTEIN-1 ALPHA (CCL3) WITH HEPARIN COMPLEX
144, d3tn1B1, 0.7365, 2.14, 0.095, 71, 63,  
145, d5ekiC_, 0.7364, 1.78, 0.200, 61, 60, CRYSTAL STRUCTURE OF TRUNCATED CCL21
146, d5l2uF_, 0.7361, 2.02, 0.175, 76, 63, OLIGOMER CRYSTAL STRUCTURE OF CC CHEMOKINE 5 (CCL5)
147, d5dnfE_, 0.7358, 2.02, 0.175, 76, 63, CRYSTAL STRUCTURE OF CC CHEMOKINE 5 (CCL5) OLIGOMER IN COMPLEX WITH HEPARIN
148, d5corB_, 0.7358, 1.94, 0.213, 67, 61, X-RAY STRUCTURE OF MACROPHAGE INFLAMMATORY PROTEIN-1 ALPHA (CCL3) N- TERMINAL-SWITCH POLYMER
149, d4ra8A_, 0.7358, 1.97, 0.213, 67, 61, STRUCTURE ANALYSIS OF THE MIP1A P8A MUTANT
150, d1nr4D_, 0.7358, 1.83, 0.115, 70, 61, HIGH RESOLUTION CRYSTAL STRUCTURES OF THYMUS AND ACTIVATION- REGULATED CHEMOKINE
151, d3kkhE_, 0.7357, 2.08, 0.145, 64, 62,  
152, p2x6lE_, 0.7357, 2.11, 0.145, 65, 62, X-RAY STRUCTURE OF MACROPHAGE INFLAMMATORY PROTEIN-1 BETA
153, p2x69A_, 0.7356, 1.97, 0.213, 68, 61, X-RAY STRUCTURE OF MACROPHAGE INFLAMMATORY PROTEIN-1 ALPHA POLYMER
154, d5d65E_, 0.7355, 1.99, 0.213, 68, 61, X-RAY STRUCTURE OF MACROPHAGE INFLAMMATORY PROTEIN-1 ALPHA (CCL3) WITH HEPARIN COMPLEX
155, p2x69B_, 0.7355, 2.04, 0.180, 63, 61, X-RAY STRUCTURE OF MACROPHAGE INFLAMMATORY PROTEIN-1 ALPHA POLYMER
156, d5dnfB_, 0.7348, 2.03, 0.129, 66, 62, CRYSTAL STRUCTURE OF CC CHEMOKINE 5 (CCL5) OLIGOMER IN COMPLEX WITH HEPARIN
157, d5l2uA_, 0.7346, 2.03, 0.129, 66, 62, OLIGOMER CRYSTAL STRUCTURE OF CC CHEMOKINE 5 (CCL5)
158, d4ra8B_, 0.7342, 1.99, 0.213, 66, 61, STRUCTURE ANALYSIS OF THE MIP1A P8A MUTANT
159, p2x69C_, 0.7339, 2.19, 0.210, 69, 62, X-RAY STRUCTURE OF MACROPHAGE INFLAMMATORY PROTEIN-1 ALPHA POLYMER
160, d4ra8E_, 0.7338, 1.96, 0.213, 66, 61, STRUCTURE ANALYSIS OF THE MIP1A P8A MUTANT
161, p4rauO_, 0.7337, 2.10, 0.145, 65, 62, CRYSTAL STRUCTURE OF RTOFAB IN COMPLEX WITH HUMAN PF4
162, d5l2uG_, 0.7336, 2.07, 0.145, 65, 62, OLIGOMER CRYSTAL STRUCTURE OF CC CHEMOKINE 5 (CCL5)
163, p2x69E_, 0.7336, 1.97, 0.213, 69, 61, X-RAY STRUCTURE OF MACROPHAGE INFLAMMATORY PROTEIN-1 ALPHA POLYMER
164, d5d65D_, 0.7335, 1.99, 0.213, 66, 61, X-RAY STRUCTURE OF MACROPHAGE INFLAMMATORY PROTEIN-1 ALPHA (CCL3) WITH HEPARIN COMPLEX
165, d5corC_, 0.7335, 2.03, 0.213, 68, 61, X-RAY STRUCTURE OF MACROPHAGE INFLAMMATORY PROTEIN-1 ALPHA (CCL3) N- TERMINAL-SWITCH POLYMER
166, d3tn1A1, 0.7335, 1.83, 0.982, 65, 56,  
167, d4ra8C_, 0.7332, 2.07, 0.145, 64, 62, STRUCTURE ANALYSIS OF THE MIP1A P8A MUTANT
168, d5corE_, 0.7328, 2.01, 0.213, 66, 61, X-RAY STRUCTURE OF MACROPHAGE INFLAMMATORY PROTEIN-1 ALPHA (CCL3) N- TERMINAL-SWITCH POLYMER
169, p2nyzE_, 0.7327, 2.16, 0.226, 67, 62, VIRAL CHEMOKINE BINDING PROTEIN M3 FROM MURINE GAMMAHERPESVIRUS68 IN COMPLEX WITH THE C- CHEMOKINE XCL1
170, p4rauF_, 0.7326, 2.19, 0.210, 67, 62, CRYSTAL STRUCTURE OF RTOFAB IN COMPLEX WITH HUMAN PF4
171, d2x6gH_, 0.7325, 2.00, 0.213, 67, 61, X-RAY STRUCTURE OF MACROPHAGE INFLAMMATORY PROTEIN-1 ALPHA (D27A)
172, d2vxwC1, 0.7324, 1.98, 0.213, 66, 61, STRUCTURAL AND FUNCTIONAL STUDIES OF THE POTENT ANTI-HIV CHEMOKINE VARIANT P2-RANTES
173, p4rauR_, 0.7321, 2.01, 0.213, 68, 61, CRYSTAL STRUCTURE OF RTOFAB IN COMPLEX WITH HUMAN PF4
174, p4rauC_, 0.7321, 1.91, 0.220, 66, 59, CRYSTAL STRUCTURE OF RTOFAB IN COMPLEX WITH HUMAN PF4
175, d3kbxC_, 0.7319, 1.84, 0.982, 65, 56, HUMAN MACROPHAGE INFLAMMATORY PROTEIN-1 ALPHA L3M_V63M
176, d3kbxB_, 0.7319, 2.09, 0.213, 65, 61, HUMAN MACROPHAGE INFLAMMATORY PROTEIN-1 ALPHA L3M_V63M
177, d3kbxA_, 0.7319, 1.50, 0.155, 59, 58, HUMAN MACROPHAGE INFLAMMATORY PROTEIN-1 ALPHA L3M_V63M
178, d5d65A_, 0.7317, 1.87, 1.000, 65, 56, X-RAY STRUCTURE OF MACROPHAGE INFLAMMATORY PROTEIN-1 ALPHA (CCL3) WITH HEPARIN COMPLEX
179, p4rauX_, 0.7317, 1.85, 0.982, 65, 56, CRYSTAL STRUCTURE OF RTOFAB IN COMPLEX WITH HUMAN PF4
180, d1je4A_, 0.7316, 1.98, 0.217, 65, 60, SOLUTION STRUCTURE OF THE MONOMERIC VARIANT OF THE CHEMOKINE MIP-1BETA
181, d2x6gR_, 0.7311, 1.95, 0.217, 65, 60, X-RAY STRUCTURE OF MACROPHAGE INFLAMMATORY PROTEIN-1 ALPHA (D27A)
182, d1pfnC_, 0.7311, 1.97, 0.217, 65, 60, PF4-M2 CHIMERIC MUTANT WITH THE FIRST 10 N-TERMINAL RESIDUES OF R-PF4 REPLACED BY THE N-TERMINAL RESIDUES OF THE IL8 SEQUENCE. MODELS 16-27 OF A 27-MODEL SET.
183, d1nr2A_, 0.7311, 2.17, 0.210, 68, 62, HIGH RESOLUTION CRYSTAL STRUCTURES OF THYMUS AND ACTIVATION- REGULATED CHEMOKINE
184, d3kbxD_, 0.7310, 2.10, 1.000, 66, 57, HUMAN MACROPHAGE INFLAMMATORY PROTEIN-1 ALPHA L3M_V63M
185, d1nr4B_, 0.7309, 1.94, 0.113, 69, 62, HIGH RESOLUTION CRYSTAL STRUCTURES OF THYMUS AND ACTIVATION- REGULATED CHEMOKINE
186, p4rauU_, 0.7305, 2.14, 0.213, 63, 61, CRYSTAL STRUCTURE OF RTOFAB IN COMPLEX WITH HUMAN PF4
187, d3tn1C_, 0.7305, 2.09, 0.968, 68, 63,  
188, p4rauI_, 0.7302, 1.84, 0.183, 62, 60, CRYSTAL STRUCTURE OF RTOFAB IN COMPLEX WITH HUMAN PF4
189, d1nr4H_, 0.7302, 1.98, 0.217, 65, 60, HIGH RESOLUTION CRYSTAL STRUCTURES OF THYMUS AND ACTIVATION- REGULATED CHEMOKINE
190, d5d65B_, 0.7301, 1.86, 0.183, 64, 60, X-RAY STRUCTURE OF MACROPHAGE INFLAMMATORY PROTEIN-1 ALPHA (CCL3) WITH HEPARIN COMPLEX
191, d1pfnA_, 0.7298, 1.87, 0.982, 65, 56, PF4-M2 CHIMERIC MUTANT WITH THE FIRST 10 N-TERMINAL RESIDUES OF R-PF4 REPLACED BY THE N-TERMINAL RESIDUES OF THE IL8 SEQUENCE. MODELS 16-27 OF A 27-MODEL SET.
192, d5ekiF_, 0.7296, 2.00, 0.213, 65, 61, CRYSTAL STRUCTURE OF TRUNCATED CCL21
193, d5corH_, 0.7290, 2.13, 1.000, 66, 57, X-RAY STRUCTURE OF MACROPHAGE INFLAMMATORY PROTEIN-1 ALPHA (CCL3) N- TERMINAL-SWITCH POLYMER
194, d5ekiB_, 0.7289, 1.87, 0.183, 63, 60, CRYSTAL STRUCTURE OF TRUNCATED CCL21
195, d1pfnD_, 0.7288, 2.01, 0.213, 67, 61, PF4-M2 CHIMERIC MUTANT WITH THE FIRST 10 N-TERMINAL RESIDUES OF R-PF4 REPLACED BY THE N-TERMINAL RESIDUES OF THE IL8 SEQUENCE. MODELS 16-27 OF A 27-MODEL SET.
196, d3kbxE_, 0.7284, 2.14, 0.968, 68, 63, HUMAN MACROPHAGE INFLAMMATORY PROTEIN-1 ALPHA L3M_V63M
197, d1donB_, 0.7283, 1.75, 0.115, 70, 61, SOLUTION STRUCTURE OF THE MONOCYTE CHEMOATTRACTANT PROTEIN- 1 DIMER USING HETERONUCLEAR NMR 20 STRUCTURES
198, d1donA_, 0.7283, 2.03, 0.213, 68, 61, SOLUTION STRUCTURE OF THE MONOCYTE CHEMOATTRACTANT PROTEIN- 1 DIMER USING HETERONUCLEAR NMR 20 STRUCTURES
199, d2vxwA1, 0.7282, 2.14, 0.095, 71, 63, STRUCTURAL AND FUNCTIONAL STUDIES OF THE POTENT ANTI-HIV CHEMOKINE VARIANT P2-RANTES
200, p4rauL_, 0.7281, 2.08, 0.968, 68, 63, CRYSTAL STRUCTURE OF RTOFAB IN COMPLEX WITH HUMAN PF4
201, d2x6gA_, 0.7281, 1.98, 0.217, 65, 60, X-RAY STRUCTURE OF MACROPHAGE INFLAMMATORY PROTEIN-1 ALPHA (D27A)
202, d2x6gI_, 0.7272, 2.04, 0.175, 76, 63, X-RAY STRUCTURE OF MACROPHAGE INFLAMMATORY PROTEIN-1 ALPHA (D27A)
203, d1u4rB_, 0.7272, 2.04, 0.175, 76, 63, CRYSTAL STRUCTURE OF HUMAN RANTES MUTANT 44-AANA-47
204, d5wk3B_, 0.7271, 1.58, 0.155, 59, 58, CRYSTAL STRUCTURE OF THE COMPLEX BETWEEN CCL17 AND M116 FAB
205, d2r3zB1, 0.7270, 1.89, 0.982, 65, 56, CRYSTAL STRUCTURE OF MOUSE IP-10
206, d4zaiA1, 0.7268, 2.06, 0.213, 66, 61, CRYSTAL STRUCTURE OF CXCL13
207, d5cmdF_, 0.7267, 2.07, 0.213, 67, 61, OLIGOMER CRYSTAL STRUCTURE OF CC CHEMOKINE 5 (CCL5)
208, d2x6gN_, 0.7263, 2.15, 0.131, 68, 61, X-RAY STRUCTURE OF MACROPHAGE INFLAMMATORY PROTEIN-1 ALPHA (D27A)
209, d2hciA1, 0.7261, 1.73, 0.186, 63, 59, STRUCTURE OF HUMAN MIP-3A CHEMOKINE
210, d3kkhB_, 0.7257, 1.82, 0.310, 66, 58,  
211, p2x6lB_, 0.7257, 2.18, 0.290, 79, 62, X-RAY STRUCTURE OF MACROPHAGE INFLAMMATORY PROTEIN-1 BETA
212, d1u4rD_, 0.7253, 2.18, 0.290, 79, 62, CRYSTAL STRUCTURE OF HUMAN RANTES MUTANT 44-AANA-47
213, d5corI_, 0.7251, 2.05, 0.148, 63, 61, X-RAY STRUCTURE OF MACROPHAGE INFLAMMATORY PROTEIN-1 ALPHA (CCL3) N- TERMINAL-SWITCH POLYMER
214, d1pfnB_, 0.7250, 2.02, 0.213, 65, 61, PF4-M2 CHIMERIC MUTANT WITH THE FIRST 10 N-TERMINAL RESIDUES OF R-PF4 REPLACED BY THE N-TERMINAL RESIDUES OF THE IL8 SEQUENCE. MODELS 16-27 OF A 27-MODEL SET.
215, d5l2uI_, 0.7249, 1.85, 0.200, 61, 60, OLIGOMER CRYSTAL STRUCTURE OF CC CHEMOKINE 5 (CCL5)
216, d5coyB_, 0.7249, 2.13, 0.148, 65, 61, CRYSTAL STRUCTURE OF CC CHEMOKINE 5 (CCL5)
217, d4zkcB_, 0.7249, 2.13, 0.148, 65, 61, ORF CHEMOKINE BINDING PROTEIN COMPLEXED WITH CCL7
218, d2vxwD1, 0.7249, 2.15, 0.131, 68, 61, STRUCTURAL AND FUNCTIONAL STUDIES OF THE POTENT ANTI-HIV CHEMOKINE VARIANT P2-RANTES
219, d1ikmA_, 0.7243, 2.11, 0.197, 69, 61, NMR STUDY OF MONOMERIC HUMAN INTERLEUKIN-8 (30 STRUCTURES)
220, d3kkhA_, 0.7240, 2.16, 0.968, 68, 63,  
221, p2x6lA_, 0.7240, 2.00, 0.148, 65, 61, X-RAY STRUCTURE OF MACROPHAGE INFLAMMATORY PROTEIN-1 BETA
222, d1hunB_, 0.7238, 2.09, 0.148, 65, 61, SOLUTION STRUCTURE OF THE CHEMOKINE HMIP-1BETA(SLASH)ACT-2 BY MULTI-DIMENSIONAL NMR: A NOVEL CHEMOKINE DIMER
223, d1hunA_, 0.7238, 1.90, 0.203, 60, 59, SOLUTION STRUCTURE OF THE CHEMOKINE HMIP-1BETA(SLASH)ACT-2 BY MULTI-DIMENSIONAL NMR: A NOVEL CHEMOKINE DIMER
224, d3kkhC_, 0.7237, 1.67, 0.155, 59, 58,  
225, p2x6lC_, 0.7237, 2.10, 0.339, 68, 62, X-RAY STRUCTURE OF MACROPHAGE INFLAMMATORY PROTEIN-1 BETA
226, d1u4rC_, 0.7230, 2.21, 0.129, 66, 62, CRYSTAL STRUCTURE OF HUMAN RANTES MUTANT 44-AANA-47
227, d4hsvC_, 0.7228, 2.21, 0.129, 66, 62, CRYSTAL STRUCTURE OF CXCL4L1
228, d2x6gL_, 0.7226, 1.88, 0.113, 69, 62, X-RAY STRUCTURE OF MACROPHAGE INFLAMMATORY PROTEIN-1 ALPHA (D27A)
229, d1u4mB_, 0.7226, 1.88, 0.113, 69, 62, HUMAN RANTES COMPLEXED TO HEPARIN-DERIVED DISACCHARIDE III-S
230, d5dnfF_, 0.7222, 2.00, 0.115, 66, 61, CRYSTAL STRUCTURE OF CC CHEMOKINE 5 (CCL5) OLIGOMER IN COMPLEX WITH HEPARIN
231, d3kkhD_, 0.7221, 2.00, 0.115, 66, 61,  
232, p2x6lD_, 0.7221, 2.22, 0.129, 64, 62, X-RAY STRUCTURE OF MACROPHAGE INFLAMMATORY PROTEIN-1 BETA
233, d2q8tB_, 0.7220, 1.59, 0.962, 59, 52, CRYSTAL STRUCTURE OF THE CC CHEMOKINE CCL14
234, d5l2uD_, 0.7218, 1.99, 0.213, 62, 61, OLIGOMER CRYSTAL STRUCTURE OF CC CHEMOKINE 5 (CCL5)
235, d5wk3D_, 0.7217, 2.22, 0.145, 65, 62, CRYSTAL STRUCTURE OF THE COMPLEX BETWEEN CCL17 AND M116 FAB
236, d5wdzA_, 0.7216, 2.08, 0.148, 65, 61, STRUCTURE OF MONOMERIC INTERLEUKIN-8 (1-66)
237, d5dnfD_, 0.7216, 2.03, 0.115, 65, 61, CRYSTAL STRUCTURE OF CC CHEMOKINE 5 (CCL5) OLIGOMER IN COMPLEX WITH HEPARIN
238, d1b3aB_, 0.7216, 2.03, 0.115, 65, 61, TOTAL CHEMICAL SYNTHESIS AND HIGH-RESOLUTION CRYSTAL STRUCTURE OF THE POTENT ANTI-HIV PROTEIN AOP-RANTES
239, d5l2uC_, 0.7215, 2.50, 0.161, 65, 62, OLIGOMER CRYSTAL STRUCTURE OF CC CHEMOKINE 5 (CCL5)
240, d5dnfC_, 0.7214, 2.14, 0.145, 64, 62, CRYSTAL STRUCTURE OF CC CHEMOKINE 5 (CCL5) OLIGOMER IN COMPLEX WITH HEPARIN
241, d1humB_, 0.7212, 1.64, 0.190, 61, 58, SOLUTION STRUCTURE OF THE CHEMOKINE HMIP-1BETA(SLASH)ACT-2 BY MULTI-DIMENSIONAL NMR: A NOVEL CHEMOKINE DIMER
242, d1humA_, 0.7212, 1.99, 0.371, 66, 62, SOLUTION STRUCTURE OF THE CHEMOKINE HMIP-1BETA(SLASH)ACT-2 BY MULTI-DIMENSIONAL NMR: A NOVEL CHEMOKINE DIMER
243, d5dnfA_, 0.7207, 2.19, 0.161, 65, 62, CRYSTAL STRUCTURE OF CC CHEMOKINE 5 (CCL5) OLIGOMER IN COMPLEX WITH HEPARIN
244, d5dnfI_, 0.7205, 2.20, 0.145, 67, 62, CRYSTAL STRUCTURE OF CC CHEMOKINE 5 (CCL5) OLIGOMER IN COMPLEX WITH HEPARIN
245, d5dnfH_, 0.7204, 2.01, 0.148, 65, 61, CRYSTAL STRUCTURE OF CC CHEMOKINE 5 (CCL5) OLIGOMER IN COMPLEX WITH HEPARIN
246, d2x6gQ_, 0.7204, 2.19, 0.161, 65, 62, X-RAY STRUCTURE OF MACROPHAGE INFLAMMATORY PROTEIN-1 ALPHA (D27A)
247, d2r3zA1, 0.7203, 1.89, 0.113, 69, 62, CRYSTAL STRUCTURE OF MOUSE IP-10
248, d5uiwB1, 0.7202, 1.89, 0.113, 69, 62, CRYSTAL STRUCTURE OF CC CHEMOKINE RECEPTOR 5 (CCR5) IN COMPLEX WITH HIGH POTENCY HIV ENTRY INHIBITOR 5P7-CCL5
249, d2l9hD_, 0.7202, 2.09, 0.148, 65, 61, OLIGOMERIC STRUCTURE OF THE CHEMOKINE CCL5/RANTES FROM NMR MS AND SAXS DATA
250, d2l9hB_, 0.7202, 2.19, 0.161, 65, 62, OLIGOMERIC STRUCTURE OF THE CHEMOKINE CCL5/RANTES FROM NMR MS AND SAXS DATA
251, d1u4lB_, 0.7202, 2.09, 0.148, 65, 61, HUMAN RANTES COMPLEXED TO HEPARIN-DERIVED DISACCHARIDE I-S
252, d5l2uB_, 0.7196, 1.97, 0.203, 63, 59, OLIGOMER CRYSTAL STRUCTURE OF CC CHEMOKINE 5 (CCL5)
253, d5cmdD_, 0.7193, 1.92, 0.305, 67, 59, OLIGOMER CRYSTAL STRUCTURE OF CC CHEMOKINE 5 (CCL5)
254, d5l2uE_, 0.7191, 1.57, 0.140, 58, 57, OLIGOMER CRYSTAL STRUCTURE OF CC CHEMOKINE 5 (CCL5)
255, d1iklA_, 0.7188, 2.13, 0.148, 65, 61, NMR STUDY OF MONOMERIC HUMAN INTERLEUKIN-8 (MINIMIZED AVERAGE STRUCTURE)
256, d2q8tD_, 0.7187, 2.13, 0.148, 65, 61, CRYSTAL STRUCTURE OF THE CC CHEMOKINE CCL14
257, d3fpuB_, 0.7185, 2.13, 0.148, 65, 61, THE CRYSTALLOGRAPHIC STRUCTURE OF THE COMPLEX BETWEEN EVASIN-1 AND CCL3
258, d1eqtB_, 0.7183, 2.11, 0.148, 65, 61, MET-RANTES
259, d5l2uH_, 0.7180, 2.19, 0.161, 64, 62, OLIGOMER CRYSTAL STRUCTURE OF CC CHEMOKINE 5 (CCL5)
260, d2q8tC_, 0.7180, 2.12, 0.148, 65, 61, CRYSTAL STRUCTURE OF THE CC CHEMOKINE CCL14
261, d2x6gM_, 0.7179, 1.90, 0.355, 68, 62, X-RAY STRUCTURE OF MACROPHAGE INFLAMMATORY PROTEIN-1 ALPHA (D27A)
262, d1nr2B_, 0.7176, 2.17, 0.164, 64, 61, HIGH RESOLUTION CRYSTAL STRUCTURES OF THYMUS AND ACTIVATION- REGULATED CHEMOKINE
263, d5cmdC_, 0.7173, 1.63, 0.211, 66, 57, OLIGOMER CRYSTAL STRUCTURE OF CC CHEMOKINE 5 (CCL5)
264, d5cmdE_, 0.7172, 2.23, 0.145, 67, 62, OLIGOMER CRYSTAL STRUCTURE OF CC CHEMOKINE 5 (CCL5)
265, d2x6gO_, 0.7167, 2.12, 0.148, 64, 61, X-RAY STRUCTURE OF MACROPHAGE INFLAMMATORY PROTEIN-1 ALPHA (D27A)
266, d1g91A_, 0.7145, 2.30, 0.164, 65, 61, SOLUTION STRUCTURE OF MYELOID PROGENITOR INHIBITORY FACTOR- 1 (MPIF-1)
267, d2x6gG_, 0.7135, 2.04, 0.200, 62, 60, X-RAY STRUCTURE OF MACROPHAGE INFLAMMATORY PROTEIN-1 ALPHA (D27A)
268, d1b2tA1, 0.7129, 1.92, 0.186, 62, 59, SOLUTION STRUCTURE OF THE CX3C CHEMOKINE DOMAIN OF FRACTALKINE
269, d1eigA_, 0.7128, 2.18, 0.161, 64, 62, SOLUTION STRUCTURE OF THE HUMAN CHEMOKINE EOTAXIN-2
270, d5cbaE_, 0.7116, 2.24, 0.161, 64, 62, 3B4 IN COMPLEX WITH CXCL13 - 3B4-CXCL13
271, d4mheA1, 0.7116, 2.16, 0.226, 65, 62, CRYSTAL STRUCTURE OF CC-CHEMOKINE 18
272, d1bo0A_, 0.7115, 1.96, 0.183, 77, 60, MONOCYTE CHEMOATTRACTANT PROTEIN-3 NMR MINIMIZED AVERAGE STRUCTURE
273, d4rwsC_, 0.7114, 1.96, 0.183, 77, 60, CRYSTAL STRUCTURE OF CXCR4 AND VIRAL CHEMOKINE ANTAGONIST VMIP-II COMPLEX (PSI COMMUNITY TARGET)
274, d3tn2A_, 0.7112, 2.16, 0.217, 63, 60, STRUCTURE ANALYSIS OF MIP1-BETA P8A
275, d2ffkB_, 0.7112, 2.34, 0.161, 76, 62, SOLUTION STRUCTURE OF THE COMPLEX BETWEEN POXVIRUS-ENCODED CC CHEMOKINE INHIBITOR VCCI AND HUMAN MIP-1BETA MINIMIZED AVERAGE STRUCTURE
276, d1eotA_, 0.7112, 2.34, 0.161, 76, 62, SOLUTION NMR STRUCTURE OF EOTAXIN MINIMIZED AVERAGE STRUCTURE
277, d5cmdB_, 0.7110, 2.10, 0.197, 73, 61, OLIGOMER CRYSTAL STRUCTURE OF CC CHEMOKINE 5 (CCL5)
278, d2x6gP_, 0.7106, 2.10, 0.197, 73, 61, X-RAY STRUCTURE OF MACROPHAGE INFLAMMATORY PROTEIN-1 ALPHA (D27A)
279, d5wk3C_, 0.7103, 2.26, 0.310, 61, 58, CRYSTAL STRUCTURE OF THE COMPLEX BETWEEN CCL17 AND M116 FAB
280, d1u4pB_, 0.7101, 2.00, 0.258, 68, 62, CRYSTAL STRUCTURE OF HUMAN RANTES MUTANT K45E
281, d2ra4B_, 0.7096, 2.22, 0.194, 76, 62, CRYSTAL STRUCTURE OF HUMAN MONOCYTE CHEMOATTRACTANT PROTEIN 4 (MCP- 4/CCL13)
282, d2ra4A_, 0.7096, 2.22, 0.194, 76, 62, CRYSTAL STRUCTURE OF HUMAN MONOCYTE CHEMOATTRACTANT PROTEIN 4 (MCP- 4/CCL13)
283, d4hsvB_, 0.7093, 2.02, 0.200, 70, 60, CRYSTAL STRUCTURE OF CXCL4L1
284, d2eotA_, 0.7090, 2.26, 0.117, 68, 60, SOLUTION STRUCTURE OF EOTAXIN AN ENSEMBLE OF 32 NMR SOLUTION STRUCTURES
285, d2finB_, 0.7084, 1.92, 0.097, 69, 62, SOLUTION STRUCTURE OF THE COMPLEX BETWEEN POXVIRUS-ENCODED CC CHEMOKINE INHIBITOR VCCI AND HUMAN MIP-1BETA ENSEMBLE STRUCTURE
286, d2q8rF_, 0.7082, 2.43, 0.222, 74, 63, STRUCTURAL AND FUNCTIONAL CHARACTERIZATION OF CC CHEMOKINE CCL14
287, d2fj2C1, 0.7076, 2.06, 0.133, 64, 60, CRYSTAL STRUCTURE OF VIRAL MACROPHAGE INFLAMMATORY PROTEIN- II
288, d5wk3A_, 0.7075, 2.15, 0.213, 64, 61, CRYSTAL STRUCTURE OF THE COMPLEX BETWEEN CCL17 AND M116 FAB
289, d5cbaF_, 0.7068, 1.88, 0.186, 64, 59, 3B4 IN COMPLEX WITH CXCL13 - 3B4-CXCL13
290, d2hdmA_, 0.7057, 2.22, 0.131, 66, 61, SOLUTION STRUCTURE OF V21C/V59C LYMPHOTACTIN/XCL1
291, d4mheC_, 0.7056, 2.14, 0.217, 65, 60, CRYSTAL STRUCTURE OF CC-CHEMOKINE 18
292, d1o7zB_, 0.7056, 2.16, 0.217, 65, 60, CRYSTAL STRUCTURE OF IP-10 T-FORM
293, d2q8rE_, 0.7055, 1.72, 0.961, 59, 51, STRUCTURAL AND FUNCTIONAL CHARACTERIZATION OF CC CHEMOKINE CCL14
294, d2fj2D1, 0.7038, 2.13, 0.226, 74, 62, CRYSTAL STRUCTURE OF VIRAL MACROPHAGE INFLAMMATORY PROTEIN- II
295, d1mshB_, 0.7036, 1.92, 0.097, 69, 62, SOLUTION STRUCTURE OF GRO(SLASH)MELANOMA GROWTH STIMULATORY ACTIVITY DETERMINED BY 1H NMR SPECTROSCOPY
296, d2fhtA1, 0.7034, 2.12, 0.153, 63, 59, CRYSTAL STRUCTURE OF VIRAL MACROPHAGE INFLAMMATORY PROTEIN- II
297, d1mshA_, 0.7032, 1.99, 0.200, 68, 60, SOLUTION STRUCTURE OF GRO(SLASH)MELANOMA GROWTH STIMULATORY ACTIVITY DETERMINED BY 1H NMR SPECTROSCOPY
298, d2q8rH_, 0.7028, 1.84, 0.186, 62, 59, STRUCTURAL AND FUNCTIONAL CHARACTERIZATION OF CC CHEMOKINE CCL14
299, d1u4pA_, 0.7025, 2.51, 0.317, 64, 60, CRYSTAL STRUCTURE OF HUMAN RANTES MUTANT K45E
300, d2vxwB1, 0.7019, 2.15, 0.203, 74, 59, STRUCTURAL AND FUNCTIONAL STUDIES OF THE POTENT ANTI-HIV CHEMOKINE VARIANT P2-RANTES
301, d4mheB1, 0.7016, 1.97, 0.267, 61, 60, CRYSTAL STRUCTURE OF CC-CHEMOKINE 18
302, d2q8tA_, 0.7016, 1.29, 0.396, 55, 53, CRYSTAL STRUCTURE OF THE CC CHEMOKINE CCL14
303, d2fj2A1, 0.7013, 2.28, 0.164, 66, 61, CRYSTAL STRUCTURE OF VIRAL MACROPHAGE INFLAMMATORY PROTEIN- II
304, d5cbeE_, 0.7001, 2.28, 0.164, 66, 61, E10 IN COMPLEX WITH CXCL13
305, d1eihA_, 0.6990, 2.01, 0.200, 67, 60, SOLUTION STRUCTURE OF THE HUMAN CHEMOKINE EOTAXIN-2
306, d2x6gK_, 0.6988, 2.39, 0.469, 72, 64, X-RAY STRUCTURE OF MACROPHAGE INFLAMMATORY PROTEIN-1 ALPHA (D27A)
307, d1qg7A_, 0.6975, 2.00, 0.200, 68, 60, STROMA CELL-DERIVED FACTOR-1ALPHA (SDF-1ALPHA)
308, d2fj2B1, 0.6974, 2.39, 0.469, 72, 64, CRYSTAL STRUCTURE OF VIRAL MACROPHAGE INFLAMMATORY PROTEIN- II
309, d2l4nA_, 0.6968, 2.10, 0.153, 63, 59, SOLUTION STRUCTURE OF THE CHEMOKINE CCL21
310, d1msgB_, 0.6964, 2.29, 0.131, 67, 61, SOLUTION STRUCTURE OF GRO(SLASH)MELANOMA GROWTH STIMULATORY ACTIVITY DETERMINED BY 1H NMR SPECTROSCOPY
311, d1msgA_, 0.6957, 1.71, 0.140, 59, 57, SOLUTION STRUCTURE OF GRO(SLASH)MELANOMA GROWTH STIMULATORY ACTIVITY DETERMINED BY 1H NMR SPECTROSCOPY
312, d1a15A_, 0.6951, 2.06, 0.258, 68, 62, SDF-1ALPHA
313, d2mp1A_, 0.6950, 2.15, 0.153, 62, 59, SOLUTION STRUCTURE OF THE HUMAN CHEMOKINE CCL19
314, d1zxtB1, 0.6946, 2.06, 0.200, 68, 60, CRYSTAL STRUCTURE OF A VIRAL CHEMOKINE
315, d5cbeF_, 0.6941, 2.16, 0.305, 64, 59, E10 IN COMPLEX WITH CXCL13
316, p5ltlB_, 0.6927, 1.98, 0.200, 73, 60, STRUCTURE OF HUMAN CHEMOKINE CCL16 
317, d2q8rG_, 0.6927, 2.20, 0.220, 61, 59, STRUCTURAL AND FUNCTIONAL CHARACTERIZATION OF CC CHEMOKINE CCL14
318, p4hcsA_, 0.6925, 2.07, 0.254, 62, 59, STRUCTURE OF NOVEL SUBFAMILY CX CHEMOKINE SOLVED BY SULFUR SAD
319, d1cm9B_, 0.6924, 2.04, 0.200, 67, 60, CRYSTAL STRUCTURE OF VIRAL MACROPHAGE INFLAMMATORY PROTEIN-II
320, d2hccA_, 0.6918, 2.17, 0.129, 70, 62, SOLUTION STRUCTURE OF THE HUMAN CHEMOKINE HCC-2 NMR 30 STRUCTURES
321, d1cm9A_, 0.6912, 2.33, 0.492, 72, 63, CRYSTAL STRUCTURE OF VIRAL MACROPHAGE INFLAMMATORY PROTEIN-II
322, d1zxtD1, 0.6876, 2.33, 0.492, 72, 63, CRYSTAL STRUCTURE OF A VIRAL CHEMOKINE
323, p5ltlA_, 0.6852, 2.22, 0.250, 67, 60, STRUCTURE OF HUMAN CHEMOKINE CCL16 
324, d1vmpA_, 0.6847, 2.57, 0.175, 77, 63, STRUCTURE OF THE ANTI-HIV CHEMOKINE VMIP-II
325, d1zxtC1, 0.6846, 2.57, 0.175, 77, 63, CRYSTAL STRUCTURE OF A VIRAL CHEMOKINE
326, p6fgpB_, 0.6845, 1.94, 0.183, 67, 60, NMR SOLUTION STRUCTURE OF MONOMERIC CCL5 IN COMPLEX WITH A DOUBLY- SULFATED N-TERMINAL SEGMENT OF CCR5 
327, d1u4rA_, 0.6839, 2.21, 0.259, 66, 58, CRYSTAL STRUCTURE OF HUMAN RANTES MUTANT 44-AANA-47
328, p4oijA_, 0.6833, 2.07, 0.169, 68, 59, X-RAY CRYSTAL STRUCTURE OF RACEMIC NON-GLYCOSYLATED CHEMOKINE SER-CCL1
329, p4oijB_, 0.6832, 2.15, 0.153, 63, 59, X-RAY CRYSTAL STRUCTURE OF RACEMIC NON-GLYCOSYLATED CHEMOKINE SER-CCL1
330, d5izbA_, 0.6828, 2.44, 0.150, 67, 60, MURIN CXCL13 SOLUTION STRUCTURE FEATURING A FOLDED N-TERMINAL DOMAIN
331, d1hrjB_, 0.6804, 2.04, 0.203, 66, 59, HUMAN RANTES NMR 13 STRUCTURES
332, d1zxtA1, 0.6801, 2.47, 0.197, 66, 61, CRYSTAL STRUCTURE OF A VIRAL CHEMOKINE
333, d1hrjA_, 0.6794, 2.13, 0.203, 67, 59, HUMAN RANTES NMR 13 STRUCTURES
334, p4hedA_, 0.6769, 1.99, 0.183, 67, 60, ZEBRAFISH CHEMOKINE CXL1
335, p4oikB_, 0.6748, 2.10, 0.169, 67, 59, (QUASI-)RACEMIC X-RAY CRYSTAL STRUCTURE OF GLYCOSYLATED CHEMOKINE SER- CCL1.
336, p4oikA_, 0.6744, 2.17, 0.200, 71, 60, (QUASI-)RACEMIC X-RAY CRYSTAL STRUCTURE OF GLYCOSYLATED CHEMOKINE SER- CCL1.
337, d1j9oA_, 0.6739, 1.99, 0.183, 67, 60, SOLUTION STRUCTURE OF HUMAN LYMPHOTACTIN
338, d2jyoA1, 0.6733, 2.14, 0.150, 68, 60, NMR SOLUTION STRUCTURE OF HUMAN MIP-3ALPHA/CCL20
339, d4uaiA_, 0.6731, 2.27, 0.119, 62, 59, CRYSTAL STRUCTURE OF CXCL12 IN COMPLEX WITH INHIBITOR
340, d1rtnB_, 0.6716, 2.36, 0.217, 71, 60, PROTON NMR ASSIGNMENTS AND SOLUTION CONFORMATION OF RANTES A CHEMOKINE OF THE CC TYPE
341, d1rtnA_, 0.6716, 2.36, 0.217, 71, 60, PROTON NMR ASSIGNMENTS AND SOLUTION CONFORMATION OF RANTES A CHEMOKINE OF THE CC TYPE
342, d1hfgA_, 0.6715, 2.25, 0.222, 89, 63, NMR SOLUTION STRUCTURE OF VMIP-II 1-71 FROM KAPOSI S SARCOMA-ASSOCIATED HERPESVIRUS (MINIMIZED AVERAGE STRUCTURE).
343, d3hp3C_, 0.6703, 2.25, 0.222, 89, 63, CRYSTAL STRUCTURE OF CXCL12
344, d2nwgA_, 0.6703, 2.56, 0.161, 68, 62, STRUCTURE OF CXCL12:HEPARIN DISACCHARIDE COMPLEX
345, d1j8iA_, 0.6685, 2.06, 0.183, 67, 60, SOLUTION STRUCTURE OF HUMAN LYMPHOTACTIN
346, p5vodD1, 0.6668, 2.56, 0.161, 68, 62, CRYSTAL STRUCTURE OF HCMV PENTAMER IN COMPLEX WITH NEUTRALIZING ANTIBODY 9I6
347, d3hp3F_, 0.6663, 2.56, 0.161, 68, 62, CRYSTAL STRUCTURE OF CXCL12
348, d5l7mA_, 0.6659, 2.23, 0.153, 70, 59, MURIN CXCL13 SOLUTION STRUCTURE
349, d2j7zA_, 0.6657, 2.23, 0.153, 70, 59, CRYSTAL STRUCTURE OF RECOMBINANT HUMAN STROMAL CELL-DERIVED FACTOR-1ALPHA
350, d1rtoB_, 0.6654, 2.39, 0.217, 73, 60, PROTON NMR ASSIGNMENTS AND SOLUTION CONFORMATION OF RANTES A CHEMOKINE OF THE CC TYPE
351, d1rtoA_, 0.6654, 2.39, 0.217, 73, 60, PROTON NMR ASSIGNMENTS AND SOLUTION CONFORMATION OF RANTES A CHEMOKINE OF THE CC TYPE
352, d3hp3E_, 0.6649, 1.96, 0.211, 93, 57, CRYSTAL STRUCTURE OF CXCL12
353, d3hp3D_, 0.6643, 2.35, 0.197, 61, 61, CRYSTAL STRUCTURE OF CXCL12
354, d3hp3I_, 0.6618, 2.29, 0.241, 68, 58, CRYSTAL STRUCTURE OF CXCL12
355, d3gv3A_, 0.6610, 2.53, 0.164, 68, 61, CXCL12 (SDF) IN TRIGONAL SPACE GROUP
356, d2n55A1, 0.6606, 2.53, 0.164, 68, 61, STRUCTURE OF CONSTITUTIVELY MONOMERIC CXCL12 IN COMPLEX WITH THE CXCR4 N-TERMINUS
357, d3hp3G_, 0.6605, 2.16, 0.200, 71, 60, CRYSTAL STRUCTURE OF CXCL12
358, p6cwsA_, 0.6602, 2.46, 0.241, 64, 58, THE NMR SOLUTION STRUCTURE OF CCL28 
359, d3hp3J_, 0.6586, 2.33, 0.224, 68, 58, CRYSTAL STRUCTURE OF CXCL12
360, d1hfnA_, 0.6553, 1.88, 0.232, 93, 56, NMR SOLUTION STRUCTURES OF VMIP-II 1-71 FROM KAPOSI S SARCOMA-ASSOCIATED HERPESVIRUS.
361, d1a15B_, 0.6549, 1.88, 0.232, 93, 56, SDF-1ALPHA
362, p5vocD1, 0.6547, 2.67, 0.150, 65, 60, CRYSTAL STRUCTURE OF HCMV PENTAMER IN COMPLEX WITH NEUTRALIZING ANTIBODY 8I21 - LOW RESOLUTION DATASET FOR INITIAL PHASING BY SAD
363, p5vobD1, 0.6546, 2.09, 0.263, 65, 57, CRYSTAL STRUCTURE OF HCMV PENTAMER IN COMPLEX WITH NEUTRALIZING ANTIBODY 8I21
364, d2j7zB_, 0.6531, 2.51, 0.197, 88, 61, CRYSTAL STRUCTURE OF RECOMBINANT HUMAN STROMAL CELL-DERIVED FACTOR-1ALPHA
365, d1qg7B_, 0.6528, 2.44, 0.233, 68, 60, STROMA CELL-DERIVED FACTOR-1ALPHA (SDF-1ALPHA)
366, d2nwgB_, 0.6513, 2.44, 0.233, 68, 60, STRUCTURE OF CXCL12:HEPARIN DISACCHARIDE COMPLEX
367, d4uaiB_, 0.6512, 2.40, 0.150, 68, 60, CRYSTAL STRUCTURE OF CXCL12 IN COMPLEX WITH INHIBITOR
368, d2kecA_, 0.6509, 2.40, 0.150, 68, 60, STRUCTURE OF SDF-1/CXCL12
369, d3hp3B_, 0.6503, 2.28, 0.228, 61, 57, CRYSTAL STRUCTURE OF CXCL12
370, d1vmcA_, 0.6501, 2.51, 0.237, 64, 59, STROMA CELL-DERIVED FACTOR-1ALPHA (SDF-1ALPHA)
371, d1g2sA_, 0.6483, 2.66, 0.254, 65, 59, SOLUTION STRUCTURE OF EOTAXIN-3
372, d1g2tA_, 0.6467, 2.39, 0.220, 62, 59, SOLUTION STRUCTURE OF EOTAXIN-3
373, d3hp3A_, 0.6456, 2.37, 0.228, 68, 57, CRYSTAL STRUCTURE OF CXCL12
374, p2hdlA_, 0.6452, 2.31, 0.237, 65, 59, SOLUTION STRUCTURE OF BRAK/CXCL14
375, d2k04C_, 0.6432, 2.05, 0.155, 74, 58, STRUCTURE OF SDF1 IN COMPLEX WITH THE CXCR4 N-TERMINUS CONTAINING NO SULFOTYROSINES
376, p2kumA_, 0.6405, 2.48, 0.246, 63, 57, SOLUTION STRUCTURE OF THE HUMAN CHEMOKINE CCL27
377, d1mi2B_, 0.6347, 2.28, 0.200, 71, 60, SOLUTION STRUCTURE OF MURINE MACROPHAGE INFLAMMATORY PROTEIN-2 NMR 20 STRUCTURES
378, d1mi2A_, 0.6347, 2.02, 0.241, 57, 54, SOLUTION STRUCTURE OF MURINE MACROPHAGE INFLAMMATORY PROTEIN-2 NMR 20 STRUCTURES
379, d3hp3H_, 0.6332, 2.57, 0.153, 70, 59, CRYSTAL STRUCTURE OF CXCL12
380, d2kedA_, 0.6325, 2.58, 0.153, 70, 59, STRUCTURE OF SDF-1/CXCL12
381, d2k03A_, 0.6300, 2.58, 0.153, 70, 59, STRUCTURE OF SDF1 IN COMPLEX WITH THE CXCR4 N-TERMINUS CONTAINING A SULFOTYROSINE AT POSTITION 21
382, p2mpmA_, 0.6290, 2.46, 0.237, 68, 59, STRUCTURAL BASIS OF RECEPTOR SULFOTYROSINE RECOGNITION BY A CC CHEMOKINE: THE N-TERMINAL REGION OF CCR3 BOUND TO CCL11/EOTAXIN-1
383, d2k05A_, 0.6286, 2.30, 0.232, 66, 56, STRUCTURE OF SDF1 IN COMPLEX WITH THE CXCR4 N-TERMINUS CONTAINING SULFOTYROSINES AT POSTITIONS 7 12 AND 21
384, d2k05C_, 0.6278, 2.51, 0.220, 64, 59, STRUCTURE OF SDF1 IN COMPLEX WITH THE CXCR4 N-TERMINUS CONTAINING SULFOTYROSINES AT POSTITIONS 7 12 AND 21
385, d1b53B_, 0.6267, 2.39, 0.241, 67, 58, NMR STRUCTURE OF HUMAN MIP-1A D26A MINIMIZED AVERAGE STRUCTURE
386, d1b53A_, 0.6267, 2.34, 0.246, 68, 57, NMR STRUCTURE OF HUMAN MIP-1A D26A MINIMIZED AVERAGE STRUCTURE
387, d2k03C_, 0.6266, 2.12, 0.232, 62, 56, STRUCTURE OF SDF1 IN COMPLEX WITH THE CXCR4 N-TERMINUS CONTAINING A SULFOTYROSINE AT POSTITION 21
388, d1el0A_, 0.6249, 2.13, 0.232, 61, 56, SOLUTION STRUCTURE OF THE HUMAN CC CHEMOKINE I-309
389, d1hhvA_, 0.6248, 2.23, 0.241, 71, 58, SOLUTION STRUCTURE OF VIRUS CHEMOKINE VMIP-II
390, d4lmqF_, 0.6225, 2.23, 0.241, 71, 58, DEVELOPMENT AND PRECLINICAL CHARACTERIZATION OF A HUMANIZED ANTIBODY TARGETING CXCL12
391, d2k04A_, 0.6191, 2.29, 0.224, 71, 58, STRUCTURE OF SDF1 IN COMPLEX WITH THE CXCR4 N-TERMINUS CONTAINING NO SULFOTYROSINES
392, d2kolA_, 0.6190, 2.31, 0.228, 64, 57, SOLUTION STRUCTURE OF HUMAN SDF1-ALPHA H25R
393, d2keeA_, 0.6179, 2.37, 0.228, 77, 57, STRUCTURE OF SDF-1/CXCL12
394, d1ha6A_, 0.6167, 2.37, 0.228, 77, 57, NMR SOLUTION STRUCTURE OF MURINE CCL20/MIP-3A CHEMOKINE
395, d2k01C_, 0.6108, 2.45, 0.241, 68, 58, STRUCTURE OF A LOCKED SDF1 DIMER
396, d2k01A_, 0.6089, 2.49, 0.164, 88, 61, STRUCTURE OF A LOCKED SDF1 DIMER
397, d2sdfA_, 0.6070, 2.49, 0.164, 88, 61, SOLUTION NMR STRUCTURE OF STROMAL CELL-DERIVED FACTOR-1 (SDF-1) 30 STRUCTURES
398, d1b50B_, 0.6068, 2.74, 0.452, 73, 62, NMR STRUCTURE OF HUMAN MIP-1A D26A 10 STRUCTURES
399, d1b50A_, 0.6068, 2.74, 0.452, 73, 62, NMR STRUCTURE OF HUMAN MIP-1A D26A 10 STRUCTURES
400, d2cayA1, 0.6023, 2.31, 0.232, 64, 56, VPS36 N-TERMINAL PH DOMAIN
401, d1sdfA_, 0.5997, 2.45, 0.228, 68, 57, SOLUTION STRUCTURE OF STROMAL CELL-DERIVED FACTOR-1 (SDF-1) NMR MINIMIZED AVERAGE STRUCTURE
402, d2cayB1, 0.5975, 2.24, 0.263, 68, 57, VPS36 N-TERMINAL PH DOMAIN
403, d1ncvB_, 0.5890, 2.64, 0.180, 74, 61, DETERMINATION CC-CHEMOKINE MCP-3 NMR 7 STRUCTURES
404, d4lmqD_, 0.5808, 2.61, 0.237, 68, 59, DEVELOPMENT AND PRECLINICAL CHARACTERIZATION OF A HUMANIZED ANTIBODY TARGETING CXCL12
405, d2rukB_, 0.5756, 2.46, 0.246, 68, 57, SOLUTION STRUCTURE OF THE COMPLEX BETWEEN P53 TRANSACTIVATION DOMAIN 2 AND TFIIH P62 PH DOMAIN
406, d1pfjA_, 0.5745, 2.68, 0.203, 69, 59, SOLUTION STRUCTURE OF THE N-TERMINAL PH/PTB DOMAIN OF THE TFIIH P62 SUBUNIT
407, d1rjtA_, 0.5743, 2.68, 0.203, 69, 59, NMR STRUCTURE OF CXC CHEMOKINE CXCL11/ITAC
408, p4khoA1, 0.5648, 2.32, 0.246, 68, 57, STRUCTURE OF THE FACT COMPLEX SUBUNIT SPT16M
409, p3pvlA5, 0.5639, 2.35, 0.207, 74, 58, STRUCTURE OF MYOSIN VIIA MYTH4-FERM-SH3 IN COMPLEX WITH THE CEN1 OF SANS
410, d2rvbB_, 0.5628, 2.35, 0.207, 74, 58, SOLUTION STRUCTURE OF THE COMPLEX BETWEEN XPC ACIDIC DOMAIN AND TFIIH P62 PH DOMAIN
411, p2yf0A1, 0.5623, 2.41, 0.203, 73, 59, HUMAN MYOTUBULARIN RELATED PROTEIN 6 (MTMR6)
412, p5gowB_, 0.5621, 2.41, 0.203, 73, 59, SOLUTION STRUCTURE OF THE COMPLEX BETWEEN DP1 ACIDIC REGION AND TFIIH P62 PH DOMAIN
413, d2al6A2, 0.5613, 2.48, 0.236, 58, 55, FERM DOMAIN OF FOCAL ADHESION KINASE
414, d1ncvA_, 0.5586, 2.58, 0.237, 68, 59, DETERMINATION CC-CHEMOKINE MCP-3 NMR 7 STRUCTURES
415, d1m7rA1, 0.5575, 2.71, 0.241, 68, 58, CRYSTAL STRUCTURE OF MYOTUBULARIN-RELATED PROTEIN-2 (MTMR2) COMPLEXED WITH PHOSPHATE
416, p5umrA_, 0.5551, 2.45, 0.228, 68, 57, CRYSTAL STRUCTURE OF N-TERMINAL DOMAIN OF HUMAN FACT COMPLEX SUBUNIT SSRP1
417, p4tyzA_, 0.5540, 2.38, 0.203, 70, 59, CRYSTAL STRUCTURE OF THE C-TERMINAL DOMAIN OF AN UNKNOWN PROTEIN FROM LEISHMANIA INFANTUM
418, d4ny0A3, 0.5533, 2.38, 0.203, 70, 59, CRYSTAL STRUCTURE OF FERM DOMAIN OF HUMAN FOCAL ADHESION KINASE
419, d4zkbB_, 0.5529, 2.73, 0.228, 68, 57, ORF CHEMOKINE BINDING PROTEIN COMPLEXED WITH CCL3
420, d4ny0D3, 0.5528, 2.62, 0.228, 68, 57, CRYSTAL STRUCTURE OF FERM DOMAIN OF HUMAN FOCAL ADHESION KINASE
421, p4tyzB_, 0.5515, 2.40, 0.241, 67, 54, CRYSTAL STRUCTURE OF THE C-TERMINAL DOMAIN OF AN UNKNOWN PROTEIN FROM LEISHMANIA INFANTUM
422, p4cyeA3, 0.5515, 2.87, 0.224, 69, 58, CRYSTAL STRUCTURE OF AVIAN FAK FERM DOMAIN FAK31-405 AT 3.2A
423, d2j0mA2, 0.5512, 2.87, 0.224, 69, 58, CRYSTAL STRUCTURE A TWO-CHAIN COMPLEX BETWEEN THE FERM AND KINASE DOMAINS OF FOCAL ADHESION KINASE.
424, p4ioyX1, 0.5507, 2.96, 0.086, 129, 58, STRUCTURE OF THE SPT16 MIDDLE DOMAIN REVEALS FUNCTIONAL FEATURES OF THE HISTONE CHAPERONE FACT
425, p4khaA1, 0.5502, 2.96, 0.086, 129, 58, STRUCTURAL BASIS OF HISTONE H2A-H2B RECOGNITION BY THE ESSENTIAL CHAPERONE FACT
426, d2aehB2, 0.5502, 2.36, 0.236, 67, 55, FOCAL ADHESION KINASE 1
427, p4khoB1, 0.5495, 2.97, 0.086, 128, 58, STRUCTURE OF THE FACT COMPLEX SUBUNIT SPT16M
428, d1zvrA1, 0.5495, 2.73, 0.224, 76, 58, CRYSTAL STRUCTURE OF MTMR2 IN COMPLEX WITH PHOSPHATIDYLINOSITOL 35-BISPHOSPHATE
429, d2n0yA_, 0.5477, 2.19, 0.240, 55, 50, NMR STRUCTURE OF THE COMPLEX BETWEEN THE C-TERMINAL DOMAIN OF THE RIFT VALLEY FEVER VIRUS PROTEIN NSS AND THE PH DOMAIN OF THE TFB1 SUBUNIT OF TFIIH
430, d4ny0B3, 0.5465, 3.18, 0.123, 108, 57, CRYSTAL STRUCTURE OF FERM DOMAIN OF HUMAN FOCAL ADHESION KINASE
431, d1lw3A1, 0.5463, 2.96, 0.127, 108, 55, CRYSTAL STRUCTURE OF MYOTUBULARIN-RELATED PROTEIN 2 COMPLEXED WITH PHOSPHATE
432, d2cy5A_, 0.5460, 2.96, 0.127, 108, 55, CRYSTAL STRUCTURE OF PHOSPHOTYROSINE BINDING (PTB) DOMAIN OF EPIDERMAL GROWTH FACTOR RECEPTOR PATHWAY SUBSTRATE-8 (EPS8) RELATED PROTEIN 1 FROM MUS MUSCULUS (FORM-2 CRYSTAL)
433, p5iwzA3, 0.5457, 3.08, 0.186, 73, 59, SYNAPTONEMAL COMPLEX PROTEIN
434, p4gxbA2, 0.5454, 3.08, 0.186, 73, 59, STRUCTURE OF THE SNX17 ATYPICAL FERM DOMAIN BOUND TO THE NPXY MOTIF OF P-SELECTIN
435, d1y5oA1, 0.5451, 2.59, 0.135, 140, 52, NMR STRUCTURE OF THE AMINO-TERMINAL DOMAIN FROM THE TFB1 SUBUNIT OF YEAST TFIIH
436, d3zdtB3, 0.5449, 2.59, 0.135, 140, 52, CRYSTAL STRUCTURE OF BASIC PATCH MUTANT FAK FERM DOMAIN FAK31-405 K216A K218A R221A K222A
437, d2aehA2, 0.5449, 3.21, 0.055, 94, 55, FOCAL ADHESION KINASE 1
438, d1zsqA1, 0.5445, 3.21, 0.055, 94, 55, CRYSTAL STRUCTURE OF MTMR2 IN COMPLEX WITH PHOSPHATIDYLINOSITOL 3-PHOSPHATE
439, d1m7rB1, 0.5441, 3.35, 0.140, 108, 57, CRYSTAL STRUCTURE OF MYOTUBULARIN-RELATED PROTEIN-2 (MTMR2) COMPLEXED WITH PHOSPHATE
440, d2cy4A1, 0.5432, 3.13, 0.164, 88, 55, CRYSTAL STRUCTURE OF PHOSPHOTYROSINE BINDING (PTB) DOMAIN OF EPIDERMAL GROWTH FACTOR RECEPTOR PATHWAY SUBSTRATE-8 (EPS8) RELATED PROTEIN 1 FROM MUS MUSCULUS (FORM-1 CRYSTAL)
441, p4tknB2, 0.5431, 3.13, 0.164, 88, 55, STRUCTURE OF THE SNX17 FERM DOMAIN BOUND TO THE SECOND NPXF MOTIF OF KRIT1
442, d5xv8B1, 0.5429, 3.21, 0.123, 108, 57, SOLUTION STRUCTURE OF THE COMPLEX BETWEEN UVSSA ACIDIC REGION AND TFIIH P62 PH DOMAIN
443, p4tknA3, 0.5426, 3.29, 0.051, 110, 59, STRUCTURE OF THE SNX17 FERM DOMAIN BOUND TO THE SECOND NPXF MOTIF OF KRIT1
444, d2rnrB_, 0.5425, 2.62, 0.172, 76, 58, SOLUTION STRUCTURE OF THE COMPLEX BETWEEN TFIIE ALPHA C- TERMINAL ACIDIC DOMAIN AND TFIIH P62 PH DOMAIN
445, d2al6B2, 0.5404, 3.21, 0.121, 125, 58, FERM DOMAIN OF FOCAL ADHESION KINASE
446, d2mkrA_, 0.5397, 3.05, 0.170, 97, 53, STRUCTURAL CHARACTERIZATION OF A COMPLEX BETWEEN THE ACIDIC TRANSACTIVATION DOMAIN OF EBNA2 AND THE TFB1/P62 SUBUNIT OF TFIIH.
447, p4tknC3, 0.5394, 3.05, 0.170, 97, 53, STRUCTURE OF THE SNX17 FERM DOMAIN BOUND TO THE SECOND NPXF MOTIF OF KRIT1
448, p4khbD1, 0.5385, 3.27, 0.105, 109, 57, STRUCTURE OF THE SPT16D POB3N HETERODIMER
449, p4dx8A_, 0.5377, 3.27, 0.105, 109, 57, ICAP1 IN COMPLEX WITH KRIT1 N-TERMINUS
450, p2j0kA2, 0.5376, 3.27, 0.051, 109, 59, CRYSTAL STRUCTURE OF A FRAGMENT OF FOCAL ADHESION KINASE CONTAINING THE FERM AND KINASE DOMAINS.
451, p4dx8D_, 0.5371, 2.15, 0.170, 49, 47, ICAP1 IN COMPLEX WITH KRIT1 N-TERMINUS
452, p4jifA_, 0.5369, 3.30, 0.051, 109, 59, CO-CRYSTAL STRUCTURE OF ICAP1 PTB DOMAIN IN COMPLEX WITH A KRIT1 PEPTIDE
453, p4khbH1, 0.5366, 3.21, 0.107, 109, 56, STRUCTURE OF THE SPT16D POB3N HETERODIMER
454, p4z2nA1, 0.5363, 3.32, 0.051, 109, 59, CRYSTAL STRUCTURE OF HUMAN FACT SPT16 MIDDLE DOMAIN
455, d1t77A2, 0.5363, 3.22, 0.051, 106, 59, CRYSTAL STRUCTURE OF THE PH-BEACH DOMAINS OF HUMAN LRBA/BGL
456, d1t77C2, 0.5350, 3.10, 0.111, 129, 54, CRYSTAL STRUCTURE OF THE PH-BEACH DOMAINS OF HUMAN LRBA/BGL
457, d1t77B2, 0.5350, 2.80, 0.154, 138, 52, CRYSTAL STRUCTURE OF THE PH-BEACH DOMAINS OF HUMAN LRBA/BGL
458, p6c2yA4, 0.5349, 3.07, 0.053, 110, 57, HUMAN GRK2 IN COMPLEX WITH GBETAGAMMA SUBUNITS AND CCG257142 
459, p4wj7C_, 0.5343, 2.57, 0.137, 135, 51, CCM2 PTB DOMAIN IN COMPLEX WITH KRIT1 NPXY/F3
460, d2hthB1, 0.5343, 3.39, 0.136, 126, 59, STRUCTURAL BASIS FOR UBIQUITIN RECOGNITION BY THE HUMAN EAP45/ESCRT-II GLUE DOMAIN
461, d2m38A_, 0.5341, 3.04, 0.130, 115, 54, PTB DOMAIN OF AIDA1
462, p5vobC1, 0.5328, 3.33, 0.051, 109, 59, CRYSTAL STRUCTURE OF HCMV PENTAMER IN COMPLEX WITH NEUTRALIZING ANTIBODY 8I21
463, d1wg7A1, 0.5326, 3.36, 0.119, 125, 59, SOLUTION STRUCTURE OF PLECKSTRIN HOMOLOGY DOMAIN FROM HUMAN KIAA1058 PROTEIN
464, d1t77D2, 0.5322, 3.40, 0.119, 126, 59, CRYSTAL STRUCTURE OF THE PH-BEACH DOMAINS OF HUMAN LRBA/BGL
465, d5he1A3, 0.5311, 3.14, 0.170, 107, 53, HUMAN GRK2 IN COMPLEX WITH GBETAGAMMA SUBUNITS AND CCG224062
466, p4z2mB1, 0.5307, 3.14, 0.170, 107, 53, CRYSTAL STRUCTURE OF HUMAN SPT16 MID-AID/H3-H4 TETRAMER FACT HISTONE COMPLEX
467, d3v5wA3, 0.5305, 2.90, 0.111, 104, 54, HUMAN G PROTEIN-COUPLED RECEPTOR KINASE 2 IN COMPLEX WITH SOLUBLE GBETAGAMMA SUBUNITS AND PAROXETINE
468, d5gnhB1, 0.5300, 2.90, 0.111, 104, 54, MYOTUBULARIN-RELATED PROTEIN 2
469, p5wg3A3, 0.5297, 2.81, 0.109, 114, 55, HUMAN GRK2 IN COMPLEX WITH GBETAGAMMA SUBUNITS AND CCG258748
470, d2bcjA2, 0.5296, 3.47, 0.050, 109, 60, CRYSTAL STRUCTURE OF G PROTEIN-COUPLED RECEPTOR KINASE 2 IN COMPLEX WITH GALPHA-Q AND GBETAGAMMA SUBUNITS
471, d5urnA1, 0.5295, 3.35, 0.051, 110, 59, NMR STRUCTURE OF THE COMPLEX BETWEEN THE PH DOMAIN OF THE TFB1 SUBUNIT FROM TFIIH AND THE TRANSACTIVATION DOMAIN 1 OF P65
472, p4xvkA1, 0.5289, 3.36, 0.119, 126, 59, BINARY COMPLEX OF HUMAN POLYMERASE NU AND DNA WITH THE FINGER DOMAIN CLOSED
473, p2j0kB2, 0.5289, 3.36, 0.119, 126, 59, CRYSTAL STRUCTURE OF A FRAGMENT OF FOCAL ADHESION KINASE CONTAINING THE FERM AND KINASE DOMAINS.
474, p4khbB1, 0.5287, 3.54, 0.119, 125, 59, STRUCTURE OF THE SPT16D POB3N HETERODIMER
475, p5oqm11, 0.5286, 3.61, 0.131, 126, 61, STRUCTURE OF YEAST TRANSCRIPTION PRE-INITIATION COMPLEX WITH TFIIH AND CORE MEDIATOR 
476, p5oqj11, 0.5286, 3.61, 0.131, 126, 61, STRUCTURE OF YEAST TRANSCRIPTION PRE-INITIATION COMPLEX WITH TFIIH 
477, d5he3A3, 0.5286, 3.32, 0.125, 89, 56, BOVINE GRK2 IN COMPLEX WITH GBETAGAMMA SUBUNITS AND CCG224411
478, p3tvvA2, 0.5286, 3.32, 0.140, 107, 57, STRUCTURE OF THE TANDEM PH DOMAINS OF RTT106 (RESIDUES 68-315)
479, d3dcxA1, 0.5286, 2.78, 0.111, 98, 54, CRYSTAL STRUCTURE OF A DUF1696 FAMILY PROTEIN WITH A PLECKSTRIN- HOMOLOGY DOMAIN (SHEW_0819) FROM SHEWANELLA LOIHICA PV-4 AT 2.00 A RESOLUTION
480, p4khbF1, 0.5284, 3.30, 0.140, 108, 57, STRUCTURE OF THE SPT16D POB3N HETERODIMER
481, p4qxaB_, 0.5283, 3.30, 0.068, 122, 59, CRYSTAL STRUCTURE OF THE RAB9A-RUTBC2 RBD COMPLEX
482, p4mk0A4, 0.5279, 3.30, 0.068, 122, 59, CRYSTAL STRUCTURE OF G PROTEIN-COUPLED RECEPTOR KINASE 2 IN COMPLEX WITH A A RATIONALLY DESIGNED PAROXETINE DERIVATIVE
483, p3gyoA2, 0.5279, 2.89, 0.109, 115, 55, SE-MET RTT106P
484, p5wg4A4, 0.5277, 3.16, 0.105, 99, 57, HUMAN GRK2 IN COMPLEX WITH GBETAGAMMA SUBUNITS AND CCG257284
485, d1v5mA1, 0.5272, 2.89, 0.143, 95, 49, SOLUTION STRUCTURE OF THE PLECKSTRIN HOMOLOGY DOMAIN OF MOUSE APS
486, p4ekuA1, 0.5270, 3.91, 0.049, 139, 61, CRYSTAL STRUCTURE OF FERM DOMAIN OF PROLINE-RICH TYROSINE KINASE 2
487, d3cikA3, 0.5270, 3.91, 0.049, 139, 61, HUMAN GRK2 IN COMPLEX WITH GBETAGAMMA SUBUNITS
488, p3aj4A_, 0.5266, 2.97, 0.055, 119, 55, CRYSTAL STRUCTURE OF THE PH DOMAIN OF EVECTIN-2 FROM HUMAN COMPLEXED WITH O-PHOSPHO-L-SERINE
489, p4wj7B_, 0.5263, 3.84, 0.065, 133, 62, CCM2 PTB DOMAIN IN COMPLEX WITH KRIT1 NPXY/F3
490, d1omwA2, 0.5263, 3.70, 0.113, 130, 62, CRYSTAL STRUCTURE OF THE COMPLEX BETWEEN G PROTEIN-COUPLED RECEPTOR KINASE 2 AND HETEROTRIMERIC G PROTEIN BETA 1 AND GAMMA 2 SUBUNITS
491, p5wg5A3, 0.5261, 2.98, 0.160, 96, 50, HUMAN GRK2 IN COMPLEX WITH GBETAGAMMA SUBUNITS AND CCG224061
492, d2n23A1, 0.5259, 3.47, 0.109, 141, 55, NMR STRUCTURE OF THE COMPLEX BETWEEN THE PH DOMAIN OF THE TFB1 SUBUNIT FROM TFIIH AND THE N-TERMINAL ACTIVATION DOMAIN OF EKLF (TAD1)
493, p4a5kA_, 0.5258, 3.24, 0.109, 110, 55, STRUCTURAL ANALYSES OF SLM1-PH DOMAIN DEMONSTRATE LIGAND BINDING IN THE NON-CANONICAL SITE
494, p5vocC1, 0.5255, 3.24, 0.109, 110, 55, CRYSTAL STRUCTURE OF HCMV PENTAMER IN COMPLEX WITH NEUTRALIZING ANTIBODY 8I21 - LOW RESOLUTION DATASET FOR INITIAL PHASING BY SAD
495, d3pvuA3, 0.5249, 3.24, 0.109, 110, 55, BOVINE GRK2 IN COMPLEX WITH GBETAGAMMA SUBUNITS AND A SELECTIVE KINASE INHIBITOR (CMPD101)
496, d4pnkA3, 0.5248, 2.95, 0.094, 110, 53, G PROTEIN-COUPLED RECEPTOR KINASE 2 IN COMPLEX WITH GSK180736A
497, d5ukkA3, 0.5247, 3.15, 0.143, 98, 56, HUMAN GRK2 IN COMPLEX WITH HUMAN G-BETA-GAMMA SUBUNITS AND CCG211998 (14AK)
498, d2m14A1, 0.5246, 3.41, 0.071, 129, 56, NMR STRUCTURE OF THE COMPLEX BETWEEN THE PH DOMAIN OF THE TFB1 SUBUNIT FROM TFIIH AND RAD4
499, d5uklA3, 0.5245, 3.33, 0.155, 129, 58, HUMAN GRK2 IN COMPLEX WITH GBETAGAMMA SUBUNITS AND CCG222886 (14BD)
500, p3uozB1, 0.5244, 3.33, 0.155, 129, 58, CRYSTAL STRUCTURE OF OTEMO COMPLEX WITH FAD AND NADP (FORM 2)
501, d3pscA3, 0.5241, 3.26, 0.069, 135, 58, BOVINE GRK2 IN COMPLEX WITH GBETAGAMMA SUBUNITS
502, p2d9wA_, 0.5239, 3.26, 0.069, 135, 58, SOLUTION STRUCTURE OF THE PH DOMAIN OF DOCKING PROTEIN 2 FROM HUMAN
503, p2dhiA_, 0.5233, 2.55, 0.077, 55, 52, SOLUTION STRUCTURE OF THE PH DOMAIN OF EVECTIN-2 FROM MOUSE
504, d5ukmA3, 0.5232, 3.12, 0.050, 137, 60, BOVINE GRK2 IN COMPLEX WITH HUMAN GBETAGAMMA SUBUNITS AND CCG258208 (14AS)
505, p3tvvB2, 0.5231, 3.12, 0.050, 137, 60, STRUCTURE OF THE TANDEM PH DOMAINS OF RTT106 (RESIDUES 68-315)
506, p4dx8B_, 0.5228, 2.91, 0.096, 110, 52, ICAP1 IN COMPLEX WITH KRIT1 N-TERMINUS
507, d5he2A3, 0.5227, 3.15, 0.143, 119, 56, BOVINE GRK2 IN COMPLEX WITH GBETAGAMMA SUBUNITS AND CCG224406
508, p4a5kD_, 0.5222, 3.47, 0.107, 144, 56, STRUCTURAL ANALYSES OF SLM1-PH DOMAIN DEMONSTRATE LIGAND BINDING IN THE NON-CANONICAL SITE
509, d1ym7B2, 0.5221, 3.47, 0.107, 144, 56, G PROTEIN-COUPLED RECEPTOR KINASE 2 (GRK2)
510, p2k2jA_, 0.5220, 3.20, 0.143, 112, 56, NMR SOLUTION STRUCTURE OF THE SPLIT PH DOMAIN FROM PHOSPHOLIPASE C GAMMA 2
511, p4wj7A_, 0.5219, 3.32, 0.145, 118, 55, CCM2 PTB DOMAIN IN COMPLEX WITH KRIT1 NPXY/F3
512, p2w2xC_, 0.5219, 3.23, 0.143, 107, 56, COMPLEX OF RAC2 AND PLCG2 SPPH DOMAIN
513, d1ym7D2, 0.5218, 3.25, 0.140, 118, 57, G PROTEIN-COUPLED RECEPTOR KINASE 2 (GRK2)
514, d1ym7A2, 0.5217, 3.30, 0.125, 114, 56, G PROTEIN-COUPLED RECEPTOR KINASE 2 (GRK2)
515, p4dx8E_, 0.5216, 3.32, 0.050, 233, 60, ICAP1 IN COMPLEX WITH KRIT1 N-TERMINUS
516, d1ym7C2, 0.5214, 3.16, 0.054, 119, 56, G PROTEIN-COUPLED RECEPTOR KINASE 2 (GRK2)
517, d5he0A3, 0.5213, 2.94, 0.143, 97, 49, BOVINE GRK2 IN COMPLEX WITH GBETAGAMMA SUBUNITS AND CCG215022
518, p4a5kC_, 0.5212, 2.68, 0.098, 108, 51, STRUCTURAL ANALYSES OF SLM1-PH DOMAIN DEMONSTRATE LIGAND BINDING IN THE NON-CANONICAL SITE
519, d3pvwA3, 0.5210, 2.68, 0.098, 108, 51, BOVINE GRK2 IN COMPLEX WITH GBETAGAMMA SUBUNITS AND A SELECTIVE KINASE INHIBITOR (CMPD103A)
520, d3krwA3, 0.5210, 3.18, 0.143, 121, 56, HUMAN GRK2 IN COMPLEX WITH GBETGAMMA SUBUNITS AND BALANOL (SOAK)
521, p3viaA_, 0.5209, 3.53, 0.145, 91, 55, CRYSTAL STRUCTURE OF THE PH DOMAIN OF EVECTIN-2 FROM HUMAN
522, p3gypA2, 0.5207, 2.83, 0.255, 113, 51, RTT106P
523, p5umuA1, 0.5202, 2.83, 0.255, 113, 51, CRYSTAL STRUCTURE OF THE MIDDLE DOUBLE PH DOMAIN OF HUMAN FACT COMPLEX SUBUNIT SPT16
524, d1foeA2, 0.5200, 2.94, 0.143, 98, 49, CRYSTAL STRUCTURE OF RAC1 IN COMPLEX WITH THE GUANINE NUCLEOTIDE EXCHANGE REGION OF TIAM1
525, p3uztA3, 0.5187, 2.94, 0.143, 98, 49, STRUCTURE OF THE C13.18 RNA APTAMER IN COMPLEX WITH G PROTEIN-COUPLED RECEPTOR KINASE 2
526, d2otxB_, 0.5186, 3.71, 0.089, 147, 56, CRYSTAL STRUCTURE OF A N-TERMINAL FRAGMENT OF SKAP-HOM CONTAINING BOTH THE HELICAL DIMERIZATION DOMAIN AND THE PH DOMAIN
527, p4v98W_, 0.5183, 3.71, 0.089, 147, 56, 
528, p4v98YC_, 0.5176, 3.19, 0.143, 99, 56, 
529, p3tw1A2, 0.5176, 3.37, 0.173, 85, 52, STRUCTURE OF RTT106-AHN
530, p3pp2B_, 0.5173, 3.19, 0.143, 96, 56, CRYSTAL STRUCTURE OF THE PLECKSTRIN HOMOLOGY DOMAIN OF ARHGAP27
531, d1m7eB_, 0.5172, 3.06, 0.091, 123, 55, CRYSTAL STRUCTURE OF THE PHOSPHOTYROSINE BINDING DOMAIN(PTB) OF MOUSE DISABLED 2(DAB2):IMPLICATIONS FOR REELING SIGNALING
532, p4a6fB_, 0.5171, 3.06, 0.091, 123, 55, CRYSTAL STRUCTURE OF SLM1-PH DOMAIN IN COMPLEX WITH PHOSPHOSERINE
533, p4v98CD_, 0.5169, 3.30, 0.107, 106, 56, 
534, d3krxA3, 0.5169, 3.30, 0.107, 106, 56, HUMAN GRK2 IN COMPLEX WITH GBETGAMMA SUBUNITS AND BALANOL (CO-CRYSTAL)
535, d1fb8A_, 0.5169, 3.17, 0.143, 115, 56, STRUCTURE OF THE PLECKSTRIN HOMOLOGY DOMAIN FROM DAPP1/PHISH
536, d1m7eC_, 0.5168, 3.15, 0.111, 112, 54, CRYSTAL STRUCTURE OF THE PHOSPHOTYROSINE BINDING DOMAIN(PTB) OF MOUSE DISABLED 2(DAB2):IMPLICATIONS FOR REELING SIGNALING
537, d5gnhA1, 0.5167, 3.43, 0.071, 132, 56, MYOTUBULARIN-RELATED PROTEIN 2
538, p3voqA_, 0.5165, 3.25, 0.143, 113, 56, CRYSTAL STRUCTURE OF THE PLECKSTRIN HOMOLOGY DOMAIN OF HUMAN SIN1 A TORC2 SUBUNIT
539, p4v98YA_, 0.5164, 3.35, 0.143, 110, 56, 
540, p5yi8A_, 0.5162, 2.96, 0.127, 114, 55, CRYSTAL STRUCTURE OF DROSOPHILA NUMB PTB DOMAIN AND PON PEPTIDE COMPLEX 
541, d5d3wA1, 0.5162, 3.21, 0.105, 115, 57, CRYSTAL STRUCTURE OF THE P-REX1 PH DOMAIN WITH SULFATE BOUND
542, p3viaB_, 0.5154, 2.61, 0.077, 60, 52, CRYSTAL STRUCTURE OF THE PH DOMAIN OF EVECTIN-2 FROM HUMAN
543, p3u12B_, 0.5154, 2.61, 0.077, 60, 52, THE PLECKSTRIN HOMOLOGY (PH) DOMAIN OF USP37
544, d1mphA_, 0.5154, 3.23, 0.143, 113, 56, PLECKSTRIN HOMOLOGY DOMAIN FROM MOUSE BETA-SPECTRIN NMR 50 STRUCTURES
545, p4xuuD_, 0.5152, 3.21, 0.143, 119, 56, THE HSAC2 DOMAIN FROM HUMAN PHOSPHOINOSITIDE PHOSPHATASE SAC2
546, d2hbjA2, 0.5151, 3.14, 0.143, 118, 56, STRUCTURE OF THE YEAST NUCLEAR EXOSOME COMPONENT RRP6P REVEALS AN INTERPLAY BETWEEN THE ACTIVE SITE AND THE HRDC DOMAIN
547, p2p0fA_, 0.5149, 2.90, 0.115, 114, 52, ARHGAP9 PH DOMAIN IN COMPLEX WITH INS(135)P3
548, p4f7uQ_, 0.5144, 3.20, 0.143, 122, 56, THE 6S SNRNP ASSEMBLY INTERMEDIATE
549, p2p0dA_, 0.5144, 3.20, 0.143, 122, 56, ARHGAP9 PH DOMAIN IN COMPLEX WITH INS(145)P3
550, p3zdtA2, 0.5143, 2.81, 0.100, 153, 50, CRYSTAL STRUCTURE OF BASIC PATCH MUTANT FAK FERM DOMAIN FAK31-405 K216A K218A R221A K222A
551, p6fszL_, 0.5139, 3.04, 0.148, 113, 54, struct.pdbx_descriptor              
552, d3dcxD_, 0.5139, 3.52, 0.085, 116, 59, CRYSTAL STRUCTURE OF A DUF1696 FAMILY PROTEIN WITH A PLECKSTRIN- HOMOLOGY DOMAIN (SHEW_0819) FROM SHEWANELLA LOIHICA PV-4 AT 2.00 A RESOLUTION
553, d1foeE2, 0.5137, 3.52, 0.085, 116, 59, CRYSTAL STRUCTURE OF RAC1 IN COMPLEX WITH THE GUANINE NUCLEOTIDE EXCHANGE REGION OF TIAM1
554, d5d3xA1, 0.5136, 3.32, 0.109, 120, 55, CRYSTAL STRUCTURE OF THE P-REX1 PH DOMAIN WITH INOSITOL-(1345)- TETRAKISPHOSPHATE BOUND
555, p2j0jA2, 0.5134, 3.26, 0.143, 113, 56, CRYSTAL STRUCTURE OF A FRAGMENT OF FOCAL ADHESION KINASE CONTAINING THE FERM AND KINASE DOMAINS.
556, p4a6fA_, 0.5133, 3.57, 0.145, 92, 55, CRYSTAL STRUCTURE OF SLM1-PH DOMAIN IN COMPLEX WITH PHOSPHOSERINE
557, p2e2xB2, 0.5133, 3.57, 0.145, 92, 55, SEC14 HOMOLOGY MODULE OF NEUROFIBROMIN IN COMPLEX WITH PHOSPHATITYLETHANOLAMINE
558, d1foeG2, 0.5132, 3.79, 0.113, 136, 62, CRYSTAL STRUCTURE OF RAC1 IN COMPLEX WITH THE GUANINE NUCLEOTIDE EXCHANGE REGION OF TIAM1
559, p4gouA2, 0.5129, 3.24, 0.143, 119, 56, CRYSTAL STRUCTURE OF AN RGS-RHOGEF FROM ENTAMOEBA HISTOLYTICA
560, p3f5rA_, 0.5129, 3.07, 0.105, 114, 57, THE CRYSTAL STRUCTURE OF A SUBUNIT OF THE HETERODIMERIC FACT COMPLEX (SPT16P-POB3P).
561, d3dcxB_, 0.5129, 3.29, 0.143, 104, 56, CRYSTAL STRUCTURE OF A DUF1696 FAMILY PROTEIN WITH A PLECKSTRIN- HOMOLOGY DOMAIN (SHEW_0819) FROM SHEWANELLA LOIHICA PV-4 AT 2.00 A RESOLUTION
562, d3hsaD_, 0.5126, 3.18, 0.069, 117, 58, CRYSTAL STRUCTURE OF PLECKSTRIN HOMOLOGY DOMAIN (YP_926556.1) FROM SHEWANELLA AMAZONENSIS SB2B AT 1.99 A RESOLUTION
563, p4yonA1, 0.5122, 3.18, 0.069, 117, 58, P-REX1:RAC1 COMPLEX
564, p3fssA2, 0.5122, 3.51, 0.071, 137, 56, STRUCTURE OF THE TANDEM PH DOMAINS OF RTT106
565, d1u5fA1, 0.5120, 3.51, 0.071, 137, 56, CRYSTAL STRUCTURE OF THE PH DOMAIN OF SKAP-HOM WITH 8 VECTOR-DERIVED N-TERMINAL RESIDUES
566, d2cocA1, 0.5116, 3.29, 0.069, 109, 58, SOLUTION STRUCTURE OF THE C-TERMINAL PH DOMAIN OF FYVE RHOGEF AND PH DOMAIN CONTAINING PROTEIN 3 (FGD3) FROM HUMAN
567, p4cyeB2, 0.5114, 3.30, 0.143, 102, 56, CRYSTAL STRUCTURE OF AVIAN FAK FERM DOMAIN FAK31-405 AT 3.2A
568, p4ny0C2, 0.5108, 3.29, 0.143, 104, 56, CRYSTAL STRUCTURE OF FERM DOMAIN OF HUMAN FOCAL ADHESION KINASE
569, d1foeC2, 0.5106, 3.88, 0.098, 133, 61, CRYSTAL STRUCTURE OF RAC1 IN COMPLEX WITH THE GUANINE NUCLEOTIDE EXCHANGE REGION OF TIAM1
570, p5yi7A_, 0.5105, 3.30, 0.143, 104, 56, CRYSTAL STRUCTURE OF DROSOPHILA NUMB PTB DOMAIN AND PON PEPTIDE COMPLEX 
571, p2p0hA_, 0.5098, 3.23, 0.143, 119, 56, ARHGAP9 PH DOMAIN IN COMPLEX WITH INS(134)P3
572, d5d3vA1, 0.5097, 3.12, 0.105, 113, 57, CRYSTAL STRUCTURE OF THE P-REX1 PH DOMAIN WITH CITRATE BOUND
573, p3voqB_, 0.5095, 3.26, 0.143, 113, 56, CRYSTAL STRUCTURE OF THE PLECKSTRIN HOMOLOGY DOMAIN OF HUMAN SIN1 A TORC2 SUBUNIT
574, p4dx9W_, 0.5094, 3.32, 0.143, 115, 56, ICAP1 IN COMPLEX WITH INTEGRIN BETA 1 CYTOPLASMIC TAIL
575, p5fi0C2, 0.5093, 3.14, 0.111, 112, 54, CRYSTAL STRUCTURE OF THE P-REX1 DH/PH TANDEM IN COMPLEX WITH RAC1
576, d2hblA2, 0.5093, 2.93, 0.137, 85, 51, STRUCTURE OF THE YEAST NUCLEAR EXOSOME COMPONENT RRP6P REVEALS AN INTERPLAY BETWEEN THE ACTIVE SITE AND THE HRDC DOMAIN; PROTEIN IN COMPLEX WITH MN ZN AND AMP
577, p1z87A1, 0.5092, 3.35, 0.135, 126, 52, SOLUTION STRUCTURE OF THE SPLIT PH-PDZ SUPRAMODULE OF ALPHA- SYNTROPHIN
578, d5d27A1, 0.5091, 3.23, 0.070, 160, 57, CRYSTAL STRUCTURE OF THE P-REX1 PH DOMAIN
579, d2y8fA_, 0.5089, 3.23, 0.070, 160, 57, STRUCTURE OF THE RAN-BINDING DOMAIN FROM HUMAN RANBP3 (WILD TYPE)
580, p2w2wC_, 0.5088, 3.08, 0.148, 99, 54, PLCG2 SPLIT PLECKSTRIN HOMOLOGY (PH) DOMAIN
581, d2otxA_, 0.5088, 3.67, 0.050, 168, 60, CRYSTAL STRUCTURE OF A N-TERMINAL FRAGMENT OF SKAP-HOM CONTAINING BOTH THE HELICAL DIMERIZATION DOMAIN AND THE PH DOMAIN
582, p4wj7D_, 0.5087, 2.99, 0.077, 127, 52, CCM2 PTB DOMAIN IN COMPLEX WITH KRIT1 NPXY/F3
583, d4c74A1, 0.5087, 2.99, 0.077, 127, 52, PHENYLACETONE MONOOXYGENASE: REDUCED ENZYME IN COMPLEX WITH APADP
584, p4dx9G_, 0.5085, 3.54, 0.151, 85, 53, ICAP1 IN COMPLEX WITH INTEGRIN BETA 1 CYTOPLASMIC TAIL
585, p4dx9Q_, 0.5083, 3.32, 0.088, 110, 57, ICAP1 IN COMPLEX WITH INTEGRIN BETA 1 CYTOPLASMIC TAIL
586, d1u5eB_, 0.5082, 3.25, 0.125, 150, 56, CRYSTAL STRUCTURE OF A N-TERMINAL FRAGMENT OF SKAP-HOM CONTAINING BOTH THE HELICAL DIMERIZATION DOMAIN AND THE PH DOMAIN
587, d5d3yA_, 0.5081, 3.09, 0.086, 110, 58, CRYSTAL STRUCTURE OF THE P-REX1 PH DOMAIN WITH INOSITOL-(1345)- TETRAKISPHOSPHATE BOUND
588, p5yi7C_, 0.5080, 2.99, 0.077, 127, 52, CRYSTAL STRUCTURE OF DROSOPHILA NUMB PTB DOMAIN AND PON PEPTIDE COMPLEX 
589, p4oo1J1, 0.5078, 3.40, 0.143, 115, 56, STRUCTURE OF AN RRP6-RNA EXOSOME COMPLEX BOUND TO POLY(A) RNA
590, d1u5eA1, 0.5075, 2.95, 0.145, 106, 55, CRYSTAL STRUCTURE OF A N-TERMINAL FRAGMENT OF SKAP-HOM CONTAINING BOTH THE HELICAL DIMERIZATION DOMAIN AND THE PH DOMAIN
591, d5d3yB_, 0.5074, 2.95, 0.145, 106, 55, CRYSTAL STRUCTURE OF THE P-REX1 PH DOMAIN WITH INOSITOL-(1345)- TETRAKISPHOSPHATE BOUND
592, p3to1B2, 0.5074, 3.26, 0.125, 150, 56, TWO SURFACES ON RTT106 MEDIATE HISTONE BINDING AND CHAPERONE ACTIVITY
593, p2d9vA_, 0.5074, 3.31, 0.145, 118, 55, SOLUTION STRUCTURE OF THE PH DOMAIN OF PLECKSTRIN HOMOLOGY DOMAIN-CONTAINING PROTEIN FAMILY B MEMBER 1 FROM MOUSE
594, d1qqgA1, 0.5074, 3.36, 0.070, 105, 57, CRYSTAL STRUCTURE OF THE PH-PTB TARGETING REGION OF IRS-1
595, d2dyqA_, 0.5073, 3.36, 0.070, 105, 57, CRYSTAL STRUCTURE OF THE C-TERMINAL PHOPHOTYROSINE INTERACTION DOMAIN OF HUMAN APBB3
596, p4xuuB_, 0.5071, 3.00, 0.077, 127, 52, THE HSAC2 DOMAIN FROM HUMAN PHOSPHOINOSITIDE PHOSPHATASE SAC2
597, p4dx9I_, 0.5071, 3.40, 0.000, 136, 56, ICAP1 IN COMPLEX WITH INTEGRIN BETA 1 CYTOPLASMIC TAIL
598, p3pg7A2, 0.5071, 3.10, 0.103, 148, 58, CRYSTAL STRUCTURE OF THE H. SAPIENS NF1 SEC-PH DOMAIN (DEL1750 MUTANT)
599, p2e2xA2, 0.5068, 3.02, 0.094, 112, 53, SEC14 HOMOLOGY MODULE OF NEUROFIBROMIN IN COMPLEX WITH PHOSPHATITYLETHANOLAMINE
600, p4dx9M_, 0.5067, 3.59, 0.107, 101, 56, ICAP1 IN COMPLEX WITH INTEGRIN BETA 1 CYTOPLASMIC TAIL
601, p3p7zB2, 0.5063, 3.21, 0.107, 106, 56, CRYSTAL STRUCTURE OF THE NEUROFIBROMIN SEC14-PH MODULE CONTAINING THE PATIENT DERIVED MUTATION I1584V
602, d1nu2A_, 0.5062, 3.63, 0.070, 149, 57, CRYSTAL STRUCTURE OF THE MURINE DISABLED-1 (DAB1) PTB DOMAIN-APOER2 PEPTIDE-PI-45P2 TERNARY COMPLEX
603, p3aj4B_, 0.5061, 2.80, 0.039, 292, 51, CRYSTAL STRUCTURE OF THE PH DOMAIN OF EVECTIN-2 FROM HUMAN COMPLEXED WITH O-PHOSPHO-L-SERINE
604, p2w2wA_, 0.5061, 3.36, 0.069, 119, 58, PLCG2 SPLIT PLECKSTRIN HOMOLOGY (PH) DOMAIN
605, d1oqnA_, 0.5061, 3.36, 0.069, 119, 58, CRYSTAL STRUCTURE OF THE PHOSPHOTYROSINE BINDING DOMAIN (PTB) OF MOUSE DISABLED 1 (DAB1)
606, d1kzgC2, 0.5061, 3.12, 0.075, 120, 53, DBSCDC42(Y889F)
607, d1q67A_, 0.5059, 3.12, 0.075, 120, 53, CRYSTAL STRUCTURE OF DCP1P
608, p3tfmA2, 0.5057, 3.34, 0.069, 107, 58, MYOSIN X PH1N-PH2-PH1C TANDEM
609, p4f7uP_, 0.5054, 2.93, 0.058, 116, 52, THE 6S SNRNP ASSEMBLY INTERMEDIATE
610, d1kzgA2, 0.5054, 2.84, 0.039, 253, 51, DBSCDC42(Y889F)
611, p4xuuC_, 0.5053, 3.09, 0.231, 110, 52, THE HSAC2 DOMAIN FROM HUMAN PHOSPHOINOSITIDE PHOSPHATASE SAC2
612, p3u12A_, 0.5053, 3.29, 0.105, 160, 57, THE PLECKSTRIN HOMOLOGY (PH) DOMAIN OF USP37
613, d1oqnB_, 0.5053, 3.11, 0.103, 148, 58, CRYSTAL STRUCTURE OF THE PHOSPHOTYROSINE BINDING DOMAIN (PTB) OF MOUSE DISABLED 1 (DAB1)
614, d1qqgB1, 0.5051, 2.94, 0.058, 116, 52, CRYSTAL STRUCTURE OF THE PH-PTB TARGETING REGION OF IRS-1
615, p2ylzA1, 0.5049, 3.37, 0.088, 105, 57, SNAPSHOTS OF ENZYMATIC BAEYER-VILLIGER CATALYSIS: OXYGEN ACTIVATION AND INTERMEDIATE STABILIZATION: MET446GLY MUTANT
616, d2fjlA1, 0.5049, 3.19, 0.170, 106, 53, SOLUTION STRUCTURE OF THE SPLIT PH DOMAIN IN PHOSPHOLIPASE C-GAMMA1
617, d1m7eA_, 0.5047, 3.22, 0.107, 160, 56, CRYSTAL STRUCTURE OF THE PHOSPHOTYROSINE BINDING DOMAIN(PTB) OF MOUSE DISABLED 2(DAB2):IMPLICATIONS FOR REELING SIGNALING
618, p5k36J1, 0.5045, 2.94, 0.096, 153, 52, STRUCTURE OF AN ELEVEN COMPONENT NUCLEAR RNA EXOSOME COMPLEX BOUND TO RNA
619, d3hsaE_, 0.5040, 2.94, 0.096, 153, 52, CRYSTAL STRUCTURE OF PLECKSTRIN HOMOLOGY DOMAIN (YP_926556.1) FROM SHEWANELLA AMAZONENSIS SB2B AT 1.99 A RESOLUTION
620, p5vzjJ1, 0.5038, 3.06, 0.140, 112, 50, STRUCTURE OF A TWELVE COMPONENT MPP6-NUCLEAR RNA EXOSOME COMPLEX BOUND TO RNA
621, p4dx9C_, 0.5037, 3.06, 0.140, 112, 50, ICAP1 IN COMPLEX WITH INTEGRIN BETA 1 CYTOPLASMIC TAIL
622, p3pp2A_, 0.5035, 3.21, 0.231, 110, 52, CRYSTAL STRUCTURE OF THE PLECKSTRIN HOMOLOGY DOMAIN OF ARHGAP27
623, d2lulA1, 0.5035, 3.22, 0.189, 100, 53, SOLUTION NMR STRUCTURE OF PH DOMAIN OF TYROSINE-PROTEIN KINASE TEC FROM HOMO SAPIENS NORTHEAST STRUCTURAL GENOMICS CONSORTIUM (NESG) TARGET HR3504C
624, p3p7zA2, 0.5034, 3.09, 0.105, 137, 57, CRYSTAL STRUCTURE OF THE NEUROFIBROMIN SEC14-PH MODULE CONTAINING THE PATIENT DERIVED MUTATION I1584V
625, p3to1A2, 0.5033, 3.41, 0.135, 85, 52, TWO SURFACES ON RTT106 MEDIATE HISTONE BINDING AND CHAPERONE ACTIVITY
626, d1xcgE2, 0.5033, 3.13, 0.037, 111, 54, CRYSTAL STRUCTURE OF HUMAN RHOA IN COMPLEX WITH DH/PH FRAGMENT OF PDZRHOGEF
627, p4dx9Y_, 0.5031, 2.97, 0.054, 99, 56, ICAP1 IN COMPLEX WITH INTEGRIN BETA 1 CYTOPLASMIC TAIL
628, p2w2wF_, 0.5031, 2.97, 0.054, 99, 56, PLCG2 SPLIT PLECKSTRIN HOMOLOGY (PH) DOMAIN
629, p4dx9S_, 0.5029, 3.16, 0.057, 116, 53, ICAP1 IN COMPLEX WITH INTEGRIN BETA 1 CYTOPLASMIC TAIL
630, d2ylsA1, 0.5026, 3.24, 0.056, 116, 54, SNAPSHOTS OF ENZYMATIC BAEYER-VILLIGER CATALYSIS: OXYGEN ACTIVATION AND INTERMEDIATE STABILIZATION: REDUCED ENZYME BOUND TO NADP
631, d5jhgE2, 0.5025, 3.23, 0.053, 160, 57, CRYSTAL STRUCTURE OF THE COMPLEX BETWEEN THE HUMAN RHOA AND THE DH/PH DOMAIN OF HUMAN ARHGEF11
632, p4dx9c_, 0.5025, 3.39, 0.000, 128, 56, ICAP1 IN COMPLEX WITH INTEGRIN BETA 1 CYTOPLASMIC TAIL
633, p4xvmA1, 0.5023, 3.31, 0.070, 118, 57, BINARY COMPLEX OF HUMAN POLYMERASE NU AND DNA WITH THE FINGER DOMAIN CLOSED AND THUMB DOMAIN ROTATED OUT
634, d2hbkA2, 0.5023, 3.13, 0.103, 148, 58, STRUCTURE OF THE YEAST NUCLEAR EXOSOME COMPONENT RRP6P REVEALS AN INTERPLAY BETWEEN THE ACTIVE SITE AND THE HRDC DOMAIN; PROTEIN IN COMPLEX WITH MN
635, p5c79B_, 0.5022, 3.43, 0.070, 102, 57, PH DOMAIN OF ASAP1 IN COMPLEX WITH DIC4-PTDINS(45)P2
636, d1kz7C2, 0.5022, 3.75, 0.070, 126, 57, CRYSTAL STRUCTURE OF THE DH/PH FRAGMENT OF MURINE DBS IN COMPLEX WITH THE PLACENTAL ISOFORM OF HUMAN CDC42
637, d5d3xB1, 0.5021, 3.11, 0.103, 136, 58, CRYSTAL STRUCTURE OF THE P-REX1 PH DOMAIN WITH INOSITOL-(1345)- TETRAKISPHOSPHATE BOUND
638, d5d3wB_, 0.5020, 3.23, 0.018, 292, 56, CRYSTAL STRUCTURE OF THE P-REX1 PH DOMAIN WITH SULFATE BOUND
639, p5c0yA1, 0.5019, 2.98, 0.071, 103, 56, CRYSTAL STRUCTURE OF THE RRP6 CATALYTIC DOMAIN BOUND TO POLY(U) RNA
640, p3a8qC1, 0.5019, 3.13, 0.103, 151, 58, LOW-RESOLUTION CRYSTAL STRUCTURE OF THE TIAM2 PHCCEX DOMAIN
641, p3a8qB1, 0.5018, 3.13, 0.103, 151, 58, LOW-RESOLUTION CRYSTAL STRUCTURE OF THE TIAM2 PHCCEX DOMAIN
642, p6am0F_, 0.5017, 3.63, 0.111, 127, 54, CRYSTAL STRUCTURE OF K. LACTIS EDC1-DCP1-DCP2-EDC3 DECAPPING COMPLEX WITH SYNTHETIC CAP SUBSTRATE ANALOG
643, p6am0B_, 0.5016, 3.24, 0.089, 105, 56, CRYSTAL STRUCTURE OF K. LACTIS EDC1-DCP1-DCP2-EDC3 DECAPPING COMPLEX WITH SYNTHETIC CAP SUBSTRATE ANALOG
644, p3a8qA1, 0.5016, 3.61, 0.033, 170, 61, LOW-RESOLUTION CRYSTAL STRUCTURE OF THE TIAM2 PHCCEX DOMAIN
645, d1ntvA_, 0.5016, 3.61, 0.033, 170, 61, CRYSTAL STRUCTURE OF THE DISABLED-1 (DAB1) PTB DOMAIN- APOER2 PEPTIDE COMPLEX
646, p3a8qD1, 0.5015, 3.37, 0.093, 123, 54, LOW-RESOLUTION CRYSTAL STRUCTURE OF THE TIAM2 PHCCEX DOMAIN
647, d1zc4D_, 0.5015, 2.96, 0.104, 296, 48, CRYSTAL STRUCTURE OF THE RAL-BINDING DOMAIN OF EXO84 IN COMPLEX WITH THE ACTIVE RALA
648, p3pg7B2, 0.5013, 3.75, 0.069, 125, 58, CRYSTAL STRUCTURE OF THE H. SAPIENS NF1 SEC-PH DOMAIN (DEL1750 MUTANT)
649, p3uzsA4, 0.5010, 3.58, 0.055, 120, 55, STRUCTURE OF THE C13.28 RNA APTAMER BOUND TO THE G PROTEIN-COUPLED RECEPTOR KINASE 2-HETEROTRIMERIC G PROTEIN BETA 1 AND GAMMA 2 SUBUNIT COMPLEX
650, p2da0A_, 0.5009, 3.40, 0.036, 168, 56, SOLUTION STRUCTURE OF THE PH DOMAIN OF PIP2-DEPENDENT ARF1 GTPASE-ACTIVATING PROTEIN FROM HUMAN
651, p5c0xK2, 0.5008, 3.24, 0.102, 136, 59, STRUCTURE OF A 12-SUBUNIT NUCLEAR EXOSOME COMPLEX BOUND TO STRUCTURED RNA
652, p5c0wK2, 0.5007, 3.28, 0.000, 131, 55, STRUCTURE OF A 12-SUBUNIT NUCLEAR EXOSOME COMPLEX BOUND TO SINGLE- STRANDED RNA SUBSTRATES
653, d1zc3D_, 0.5007, 3.14, 0.035, 293, 57, CRYSTAL STRUCTURE OF THE RAL-BINDING DOMAIN OF EXO84 IN COMPLEX WITH THE ACTIVE RALA
654, d5jhhE2, 0.5004, 3.48, 0.034, 168, 58, CRYSTAL STRUCTURE OF THE TERNARY COMPLEX BETWEEN THE HUMAN RHOA ITS INHIBITOR AND THE DH/PH DOMAIN OF HUMAN ARHGEF11
655, p5fi1A1, 0.5003, 3.24, 0.102, 136, 59, CRYSTAL STRUCTURE OF THE P-REX1 DH/PH TANDEM IN COMPLEX WITH CDC42
656, p4dx9g_, 0.5003, 3.48, 0.135, 83, 52, ICAP1 IN COMPLEX WITH INTEGRIN BETA 1 CYTOPLASMIC TAIL
657, p2w2wG_, 0.5003, 3.47, 0.148, 120, 54, PLCG2 SPLIT PLECKSTRIN HOMOLOGY (PH) DOMAIN
658, d2hbmA2, 0.5003, 3.47, 0.148, 120, 54, STRUCTURE OF THE YEAST NUCLEAR EXOSOME COMPONENT RRP6P REVEALS AN INTERPLAY BETWEEN THE ACTIVE SITE AND THE HRDC DOMAIN; PROTEIN IN COMPLEX WITH MN ZN AND UMP
659, p4a6kC_, 0.5002, 3.04, 0.019, 103, 52, CRYSTAL STRUCTURE OF SLM1-PH DOMAIN IN COMPLEX WITH D-MYO-INOSITOL-4-PHOSPHATE
660, d3dcxC_, 0.5001, 3.24, 0.127, 118, 55, CRYSTAL STRUCTURE OF A DUF1696 FAMILY PROTEIN WITH A PLECKSTRIN- HOMOLOGY DOMAIN (SHEW_0819) FROM SHEWANELLA LOIHICA PV-4 AT 2.00 A RESOLUTION
